Zoomcar Holdings, Inc SC TO-I, filed Jan 23, 2026
Zoomcar Holdings, Inc. (ZCAR)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE TO
TENDER OFFER STATEMENT UNDER SECTION 14(d)(1)
OR 13(e)(1)
OF THE SECURITIES EXCHANGE ACT OF 1934
ZOOMCAR HOLDINGS, INC.
(Name of Subject Company and Filing Person (Issuer))
|
Common Stock Purchase Warrants Series A Common Stock Purchase Warrants Series B Common Stock Purchase Warrants Pre-Funded Warrants to Purchase Common Stock |
N/A |
|
| (Title of Class of Securities) | (CUSIP Number of Class of Securities) |
Deepankar Tiwari
Anjaneya Techno Park, No.147, 1st
Floor
Kodihalli, Bangalore, India 560008
+91 8048821871
(Name, address, and telephone numbers of person authorized to receive notices and communications on behalf of filing persons)
Copies of communications to:
Morris C. Zarif, Esq.
Zarif Law Group P.C.
808 Springwood Avenue, Suite 110
Asbury Park, NJ 07711
(732) 755-0146
| ☐ | Check the box if the filing relates solely to preliminary communications before the commencement of a tender offer. |
Check the appropriate boxes below to designate any transactions to which the statement relates:
| ☐ | third-party tender offer subject to Rule 14d-1. | |
| ☒ | issuer tender offer subject to Rule 13e-4. | |
| ☐ | going-private transaction subject to Rule 13e-3. | |
| ☐ | amendment to Schedule 13D under Rule 13d-2. |
Check the following box if the filing is a final amendment reporting the results of the tender offer: ☐
If applicable, check the appropriate box(es) below to designate the appropriate rule provision(s) relied upon:
| ☐ | Rule 13e-4(i) (Cross-Border Issuer Tender Offer) | |
| ☐ | Rule 14d-1(d) (Cross-Border Third-Party Tender Offer) |
SCHEDULE TO
This Tender Offer Statement on Schedule TO (this “Schedule TO”) is filed by Zoomcar Holdings, Inc., a Delaware corporation (the “Company,” “Zoomcar,” “we,” “us,” or “our”). This Schedule TO relates to the offer by the Company to eligible holders of (i) the Company’s outstanding common stock purchase warrants (the “Common Warrants”), (ii) the Company’s outstanding Series A common stock purchase warrants (the “Series A Warrants”), (iii) the Company’s outstanding Series B common stock purchase warrants (the “Series B Warrants”), (iv) the Company’s outstanding pre-funded warrants to purchase shares of the Company’s common stock (the “Pre-Funded Warrants”), (v) the Company’s Bridge Placement Agent common stock purchase warrants (the “Bridge Placement Agent Warrants”) issued in connection with the Company’s private placement entered into on June 18, 2024 and consummated on June 20, 2024 , (vi) the Company’s Placement Agent common stock purchase warrants issued in connection with the Company’s private placement entered into on November 5, 2024 and consummated on November 7, 2024 (the “Placement Agent Warrants”), and (vii) the Company’s Series A Placement Agent warrants issued in connection with the same November 7, 2024 private placement (the “Series A Placement Agent Warrants,” and together with the Common Warrants, the Series A Warrants, the Series B Warrants, the Bridge Placement Agent Warrants, and the Placement Agent Warrants, the “Existing Warrants”), to exchange the Existing Warrants for shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), upon the terms and subject to the conditions set forth in the Company’s offer to exchange, dated January 23, 2026, as it may be amended or supplemented from time to time (the “Offer to Exchange”), and the related letter(s) of transmittal and consent, notice(s) of withdrawal, and other offer materials (together with the Offer to Exchange, as amended or supplemented from time to time, the “Offer Materials”), each of which are filed as exhibits to this Schedule TO.
Under the Offer to Exchange, subject to the terms and conditions described in the Offer Materials, the Company is offering to eligible holders: (1) for each one (1) Common Warrant tendered and accepted for exchange, twenty thousand (20,000) shares of Common Stock; (2) for each one (1) Series A Warrant tendered and accepted for exchange, ten (10) shares of Common Stock; (3) for each one (1) Series B Warrant tendered and accepted for exchange, ten (10) shares of Common Stock; (4) for each one (1) Pre-Funded Warrant tendered and accepted for exchange, ten (10) shares of Common Stock; (5) for each one (1) Bridge Placement Agent Warrants tendered and accepted for exchange, ten (10) shares of Common Stock; (6) for each one (1) Placement Agent Warrant tendered and accepted for exchange, ten (10) shares of Common Stock; and (7) for each one (1) Series A Placement Agent Warrant tendered and accepted for exchange, ten (10) shares of Common Stock (each, an “Exchange Ratio,” and collectively, the “Exchange Ratios”)
Participants whose Existing Warrants are tendered and accepted for exchange will be required, as a condition to receiving shares of Common Stock in the Offer to Exchange, to execute and deliver a lock-up agreement in favor of the Company (the “Lock-Up Agreement”) pursuant to which 50% of the shares of Common Stock issued to such participant in the Offer to Exchange will be subject to transfer restrictions until the date that is twelve (12) months after the Expiration Date (as it may be extended) and the remaining 50% of such shares will be subject to transfer restrictions until the date that is eighteen (18) months after the Expiration Date (as it may be extended).
In addition, concurrently with the Offer to Exchange, the Company may solicit consents from holders of certain classes of Existing Warrants to amend the governing warrant instruments and related agreements to facilitate the Offer to Exchange and/or the post-offer treatment of any Existing Warrants that remain outstanding (the “Warrant Amendments”). The Series A Warrants and Series B Warrants may be amended as a class with the consent of holders of a majority in interest of such warrant. The scope, terms, and applicable approval thresholds for any Warrant Amendments will be described in the Offer Materials.
1
The Company intends to issue the shares of Common Stock offered in the Offer to Exchange in reliance on the exemption from registration provided by Section 3(a)(9) of the Securities Act of 1933, as amended (the “Securities Act”), and the Company is not filing a registration statement on Form S-4 or otherwise registering the issuance of such shares in connection with the Offer to Exchange. The Offer to Exchange is conditioned upon, among other things, the adoption by the Company’s stockholders of an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the number of authorized shares of Common Stock (the “Authorized Share Increase”) and the filing and effectiveness of such amendment with the Secretary of State of the State of Delaware. The Company expects to seek such stockholder approval in connection with the Company’s annual meeting of stockholders and related proxy solicitation.
This Schedule TO is intended to satisfy the reporting requirements of Rule 13e-4 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Information set forth in the Offer Materials is incorporated by reference in response to Items 1 through 13 of this Schedule TO, except to the extent that information is specifically provided herein.
Item 1. Summary Term Sheet.
The information set forth under the heading “Summary” in the Offer to Exchange is incorporated herein by reference.
Item 2. Subject Company Information.
(a) Name and Address. The name of the subject company and the filing person is Zoomcar Holdings, Inc., a Delaware corporation. Its principal executive offices are located at Anjaneya Techno Park, No.147, 1st Floor, Kodihalli, Bangalore, India 560008. The Company’s telephone number is +91 8048821871.
(b) Securities. The subject securities of this Offer to Exchange are the Existing Warrants described above. There is no trading market for the Existing Warrants. The Existing Warrants were privately issued and are not deposited with The Depository Trust Company. As of January 22, 2026, there were an aggregate of 19,369 Common Warrants, 3,312,437 Series A Warrants, 781,122 Series B Warrants, 5,306,013 Pre-Funded Warrants, 5,297 Bridge Placement Agent Warrants, 53,447 Placement Agent Warrants, and 106,893 Series A Placement Agent Warrants, outstanding and eligible to participate in the Offer to Exchange. Assuming all eligible Existing Warrants are tendered and accepted for exchange, the Company would issue an aggregate of up to 483,032,089 shares of Common Stock. The number of shares of Common Stock issuable in the Offer to Exchange is subject to the Company having a sufficient number of authorized and unissued shares of Common Stock available for issuance, including as a result of the Authorized Share Increase.
(c) Trading Market and Price. The Common Stock is quoted/traded on the OTCQB under the symbol “ZCAR” The information set forth in the Offer to Exchange under “Price Range of Common Stock” is incorporated herein by reference.
Item 3. Identity and Background of Filing Person.
(a) Name and Address. The Company is the subject company and the filing person. The address and telephone number of the Company are set forth under Item 2(a) above.
2
The names of the executive officers and directors of the Company who are persons specified in Instruction C to Schedule TO are set forth below. The business address for each such person is Anjaneya Techno Park, No.147, 1st Floor Kodihalli, Bangalore, India 560008 and the business telephone number for each such person is +91 8048821871 .
| Name | Position | |
| Uri Levine | Director | |
| Mohan Ananda | Director | |
| Evelyn D’An | Director | |
| Swatick Majumdar | Director | |
| John Clarke | Director | |
| Deepankar Tiwari | Chief Executive Officer | |
| Sachin Gupta | Chief Financial Officer | |
| Shachi Singh | Chief Legal Officer & General Counsel |
Item 4. Terms of the Transaction.
(a) Material Terms. The information set forth in the Offer to Exchange is incorporated herein by reference. As a condition to the issuance of shares of Common Stock in the Offer to Exchange, each eligible holder whose Existing Warrants are tendered and accepted for exchange will be required to execute and deliver a Lock-Up Agreement pursuant to which: (i) 50% of the shares of Common Stock issued to such holder in the Offer to Exchange will not be sold, transferred, pledged, hedged, or otherwise disposed of until the date that is twelve (12) months after the Expiration Date (as it may be extended), and (ii) the remaining 50% of such shares will not be sold, transferred, pledged, hedged, or otherwise disposed of until the date that is eighteen (18) months after the Expiration Date (as it may be extended), in each case subject to customary exceptions set forth in the Lock-Up Agreement. The Company expects that shares issued in the Offer to Exchange will bear an appropriate restrictive legend reflecting the Lock-Up Agreement and the Company may provide stop-transfer instructions to its transfer agent to enforce such restrictions.
The Offer to Exchange will commence on January 23, 2026 and will expire at 5:00 p.m., Eastern Time, on March 31, 2026, unless extended by the Company (the “Expiration Date”). Eligible holders may withdraw tendered Existing Warrants at any time prior to the Expiration Date, and as otherwise permitted under applicable law, as described in the Offer Materials. The Offer to Exchange is subject to the satisfaction (or, where applicable, waiver) of the conditions described in the Offer Materials, including the Authorized Share Increase. The Company will not accept for exchange, or issue any shares of Common Stock in exchange for, any Existing Warrants tendered pursuant to the Offer to Exchange unless and until the Authorized Share Increase has been approved by the Company’s stockholders and has become effective.
The Company reserves the right, subject to applicable law, to extend the Offer to Exchange, to amend the terms of the Offer to Exchange, or to terminate the Offer to Exchange, as described in the Offer Materials.
(b) Purchases. The information set forth in the Offer to Exchange under the section titled “Interests of Directors and Executive Officers” is incorporated herein by reference.
3
Item 5. Past Contracts, Transactions, Negotiations and Arrangements.
(a) Agreements Involving the Subject Company’s Securities. The information set forth in the Offer to Exchange under the section titled “Transactions and Agreements Concerning the Company’s Securities” is incorporated herein by reference.
Item 6. Purposes of the Transaction and Plans or Proposals.
(a) Purposes. The information set forth in the Offer to Exchange under the section titled “Background and Purpose of the Offer” is incorporated herein by reference.
(b) Use of Securities Acquired. To the extent the Company acquires Existing Warrants in the Offer to Exchange, the Company expects to cancel and retire such Existing Warrants.
(c) Plans. Except as described in the Offer Materials, including with respect to the Authorized Share Increase and the related stockholder meeting and proxy solicitation, neither the Company nor, to the Company’s knowledge, any of its directors or executive officers has any plans, proposals, or negotiations that relate to or would result in any of the transactions described in Items 1006(c)(1)-(10) of Regulation M-A.
Item 7. Source and Amount of Funds or Other Consideration.
(a) Source of Funds. No funds will be paid by the Company to holders tendering Existing Warrants in connection with the Offer to Exchange. The consideration for the Offer to Exchange consists solely of shares of Common Stock. The Company will use cash on hand to pay the fees and expenses incurred in connection with the Offer to Exchange.
(b) Conditions. Not applicable because there is no financing condition.
(c) Borrowed Funds. Not applicable because no funds are being borrowed for the Offer to Exchange.
Item 8. Interest in Securities of the Subject Company.
(a) Securities Ownership. The information set forth in the Offer to Exchange under the section titled “Interests of Directors and Executive Officers” is incorporated herein by reference.
(b) Securities Transactions. Except as disclosed in the Offer Materials, neither the Company nor, to the Company’s knowledge, any of its directors, executive officers, or affiliates has engaged in any transactions in the Existing Warrants during the past sixty (60) days.
Item 9. Persons/Assets, Retained, Employed, Compensated or Used.
(a) Solicitations or Recommendations. The Company has not retained any dealer manager or solicitation agent for the Offer to Exchange. The Company may retain an information agent and/or exchange agent to assist with the administration of the Offer to Exchange, as described in the Offer Materials. The Company’s directors and executive officers are not making any recommendation as to whether holders should tender Existing Warrants.
4
Item 10. Financial Statements.
(a) Financial Information. The Company’s financial statements and other financial information are incorporated by reference to the Company’s Annual Report on Form 10-K for the fiscal year ended 31 March 2025 filed with the SEC on 30 June 2025, the Company’s Quarterly Reports on Form 10-Q for the quarters ended 30 June 2025 filed with the SEC on 14 August 2025, and the Company’s Quarterly Reports on Form 10-Q for the quarters ended 30 September 2025 field with the SEC on 14 November 2025, and any other reports filed with the SEC and incorporated by reference in the Offer Materials.
Item 11. Additional Information.
(a) Agreements, Regulatory Requirements and Legal Proceedings.
(1) Except as set forth in the Offer Materials, there are no present or proposed contracts, arrangements, understandings or relationships between the Company and its executive officers, directors or affiliates relating, directly or indirectly, to the Offer to Exchange.
(2) In addition to the requirements of applicable U.S. federal and state securities laws and the rules and regulations of the SEC, the Company expects to seek stockholder approval of the Authorized Share Increase at the annual meeting of stockholders to be held on or prior to the Expiration Date. The Company expects to file with the SEC a preliminary proxy statement and a definitive proxy statement in connection with such meeting. The Offer to Exchange will not be consummated unless and until the Authorized Share Increase has been approved and has become effective.
(3) Not applicable.
(4) Not applicable.
(5) None.
(b) Other Material Information. The information set forth in the Offer Materials is incorporated herein by reference.
Item 12. Exhibits.
The following exhibits are filed as a part of this Schedule TO:
Item 13. Information Required by Schedule 13e-3.
Not applicable.
5
SIGNATURE
After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
| ZOOMCAR HOLDINGS, INC. | ||
| Date: January 23, 2026 | ||
| By: | /s/ Deepankar Tiwari | |
| Name: | Deepankar Tiwari | |
| Title: | Chief Executive Officer | |
6
Exhibit 99(a)(1)(A)
OFFER TO EXCHANGE COMMON STOCK
FOR CERTAIN OUTSTANDING WARRANTS OF
ZOOMCAR HOLDINGS, INC.
JANUARY 23, 2026
THE OFFER PERIOD AND YOUR RIGHT TO WITHDRAW ELIGIBLE WARRANTS THAT YOU TENDER WILL EXPIRE AT 5:00 P.M., EASTERN TIME, ON MARCH 31, 2026, UNLESS THE OFFER PERIOD IS EXTENDED. THE COMPANY MAY EXTEND THE OFFER PERIOD AT ANY TIME.
THE OFFER IS BEING MADE SOLELY UNDER THIS OFFER TO EXCHANGE AND THE RELATED LETTERS OF TRANSMITTAL AND CONSENT TO ALL HOLDERS OF THE ELIGIBLE WARRANTS DESCRIBED HEREIN. THE OFFER IS NOT BEING MADE TO, NOR WILL TENDERS BE ACCEPTED FROM OR ON BEHALF OF, HOLDERS OF ELIGIBLE WARRANTS RESIDING IN ANY U.S. STATE IN WHICH THE MAKING OF THE OFFER OR ACCEPTANCE THEREOF WOULD NOT BE IN COMPLIANCE WITH THE SECURITIES, BLUE SKY OR OTHER LAWS OF SUCH U.S. STATE.
Zoomcar Holdings, Inc., a Delaware corporation ( as “we”, “us”, “our”, “Zoomcar” or the “Company”) is making an offer, upon the terms and conditions in this Offer to Exchange and the related Letters of Transmittal and Consent applicable to each class of Eligible Warrants (which together constitute the “Offer”), to holders of certain of the Company’s outstanding privately issued warrants to receive shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock” or “Shares”), in exchange for such warrants.
The warrants subject to our Offer to Exchange consist of privately issued warrants to purchase shares of Common Stock, including (i) common stock purchase warrants (the “Common Warrants”), (ii) Series A common stock purchase warrants (the “Series A Warrants”), (iii) Series B common stock purchase warrants (the “Series B Warrants”), (iv) pre-funded warrants to purchase Common Stock (“Pre-Funded”), (v) Bridge Placement Agent common stock purchase warrants issued in connection with the Company’s private placement entered into on June 18, 2024 and consummated on June 20, 2024 (the “Bridge Placement Agent Warrants”), (vi) Placement Agent common stock purchase warrants issued in connection with the Company’s private placement entered into on November 5, 2024 and consummated on November 7, 2024 (the “Placement Agent Warrants”), Series A Placement Agent warrants issued in connection with the same November 7, 2024 private placement (the “Series A Placement Agent Warrants,” and together with the Common Warrants, Series A Warrants, Series B Warrants, Pre-Funded Warrants, Bridge Placement Agent Warrants, and Placement Agent Warrants, the “Eligible Warrants”). Only the Eligible Warrants are eligible to be tendered for exchange in this Offer.
Under this Offer to Exchange, Eligible Warrant holders will be entitled to receive the following number of Shares for each Eligible Warrant exchanged: (i) each Common Warrant tendered and accepted will be exchanged for 20,000 Shares; (ii) each Series A Warrant tendered and accepted will be exchanged for 10 Shares; (iii) each Series B Warrant tendered and accepted will be exchanged for 10 Shares; (iv) each Pre-Funded Warrant tendered and accepted will be exchanged for 10 Shares; (v) each Bridge Placement Agent Warrant tendered and accepted will be exchanged for 10 Shares; (vi) each Placement Agent Warrant tendered and accepted will be exchanged for 10 Shares; and (vii) each Series A Placement Agent Warrant tendered and accepted will be exchanged for 10 Shares (collectively, the “Exchange Ratios”).
As of January 22, 2026, the Company estimates that there are outstanding approximately (i) 19,369 Common Warrants, (ii) 3,312,437 Series A Warrants, (iii) 781,122 Series B Warrants, and (iv) 5,306, 013 Pre-Funded Warrants, (iv) 5,297 Bridge Placement Agent Warrants, (v) 53,447 Placement Agent Warrants, and (vi) 106,893 Series A Placement Agent Warrants, If all Eligible Warrants are tendered and accepted for exchange, the Company would issue an aggregate of up to approximately 483,032,089 Shares of Common Stock (subject to adjustment for transfers, cancellations and other changes in holdings and subject to the conditions of the Offer).
Our Shares are listed on the OTCQB under the symbol “ZCAR”. On January 21, 2026, the last reported closing sales price for the Shares was $0.074222 per share.
No scrip or fractional shares will be issued. Eligible Warrants may only be exchanged for whole Shares. Because the Exchange Ratios are expressed as whole Shares per Eligible Warrant, fractional shares are not expected; however, if any fractional Shares would otherwise be issuable, holders who would otherwise have been entitled to receive fractional Shares will, after aggregating all such fractional Shares of such holder, receive the number of Shares as rounded down to the nearest whole Share, as described in this Offer to Exchange.
THIS OFFER IS INTENDED TO BE MADE PURSUANT TO THE EXEMPTION FROM REGISTRATION PROVIDED BY SECTION 3(A)(9) OF THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THE COMPANY IS NOT FILING A REGISTRATION STATEMENT IN CONNECTION WITH THE OFFER. THE SHARES ISSUED IN THE OFFER ARE EXPECTED TO BE ISSUED AS “RESTRICTED SECURITIES” AND WILL BEAR AN APPROPRIATE LEGEND.
Participants whose Eligible Warrants are tendered and accepted will also be required to execute and deliver a lock-up agreement in favor of the Company as a condition to receiving Shares in the Offer, which will restrict transfers of the Shares received in the Offer as described herein.
THIS OFFER IS CONDITIONED UPON, AMONG OTHER THINGS, THE ADOPTION BY THE COMPANY’S STOCKHOLDERS OF AN AMENDMENT TO THE COMPANY’S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK (THE “AUTHORIZED SHARE INCREASE”) AND THE FILING AND EFFECTIVENESS OF SUCH AMENDMENT WITH THE SECRETARY OF STATE OF THE STATE OF DELAWARE. THE COMPANY WILL NOT ACCEPT FOR EXCHANGE, OR ISSUE ANY SHARES IN EXCHANGE FOR, ANY ELIGIBLE WARRANTS UNLESS AND UNTIL THE AUTHORIZED SHARE INCREASE HAS BEEN APPROVED AND HAS BECOME EFFECTIVE.
If you elect to tender Eligible Warrants in response to the Offer, please follow the instructions in this Offer to Exchange and the related documents, including the applicable Letter of Transmittal and Consent.
If you tender Eligible Warrants, you may withdraw your tendered Eligible Warrants before the Expiration Date and retain them on their terms (subject, in the case of Series A Warrants and Series B Warrants, to any amendments approved by the requisite holders) by following the instructions herein.
Investing in the Shares involves a high degree of risk. See the “Risk Factors” section of this Offer to Exchange for a discussion of information that you should consider before tendering Eligible Warrants in the Offer.
2
A detailed discussion of our Offer to Exchange Common Stock for the Eligible Warrants is contained in this Offer to Exchange. Eligible Warrant holders are strongly encouraged to read this entire package of materials, and the publicly filed information about the Company referenced herein, before deciding regarding the Offer.
THE COMPANY’S BOARD OF DIRECTORS HAS APPROVED THE OFFER. HOWEVER, NONE OF THE COMPANY, ITS DIRECTORS, OFFICERS OR EMPLOYEES (EACH AS DEFINED BELOW) MAKES ANY RECOMMENDATION WHETHER YOU SHOULD EXCHANGE YOUR ELIGIBLE WARRANTS. EACH HOLDER OF AN ELIGIBLE WARRANT MUST MAKE HIS, HER OR ITS OWN DECISION WHETHER TO TENDER SOME OR ALL OF HIS, HER OR ITS ELIGIBLE WARRANTS.
WE HAVE NOT AUTHORIZED ANY PERSON TO MAKE ANY RECOMMENDATION ON OUR BEHALF AS TO WHETHER OR NOT YOU SHOULD PARTICIPATE IN THE OFFER TO EXCHANGE. YOU SHOULD RELY ONLY ON THE INFORMATION CONTAINED OR INCORPORATED BY REFERENCE IN THIS DOCUMENT.
Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission, bureau or authority has approved or disapproved of this transaction or passed upon the fairness or merits of this transaction or the accuracy or adequacy of the information contained in this Offer to Exchange. Any representation to the contrary is a criminal offense.
IMPORTANT PROCEDURES
If you want to tender Eligible Warrants, you must:
| ● | complete and sign the Letter of Transmittal and Consent applicable to the Eligible Warrants you are tendering according to its instructions, and deliver the Letter of Transmittal and Consent, together with any other documents required by the applicable Letter of Transmittal and Consent, to the Exchange Agent. |
| ● | if you want to tender your Eligible Warrants, but your other required documents cannot be delivered to the Exchange Agent before the Expiration Date of the Offer, then you can still tender your Eligible Warrants if you comply with the procedures described in Section 2. |
TO TENDER YOUR ELIGIBLE WARRANTS, YOU MUST CAREFULLY FOLLOW THE PROCEDURES DESCRIBED IN THIS OFFER TO EXCHANGE, THE LETTER OF TRANSMITTAL AND CONSENT APPLICABLE TO YOUR ELIGIBLE WARRANTS AND THE OTHER DOCUMENTS DISCUSSED HEREIN RELATED TO THE OFFER. NO SCRIP OR FRACTIONAL SHARES WILL BE ISSUED. ELIGIBLE WARRANTS MAY ONLY BE EXCHANGED FOR WHOLE SHARES.
If you have any questions or need assistance, you should contact the Exchange Agent or the Company. You may request additional copies of this Offer to Exchange and the applicable Letters of Transmittal and Consent from the Company. The Exchange Agent may be reached at:
Vinyl Equity, Inc.
912 Cherry Street
Winnetka, IL
Email: inquiries@vinylequity.com
Phone: 888-808-4695
The address of the Company is:
Zoomcar Holdings, Inc.
Anjaneya Techno Park, No.147, 1st Floor,
Kodihalli, Bangalore, India 560008
Attn: Chief Legal Officer & General Counsel
Email: investors@zoomcar.com
Phone: +91 8048821871
3
TABLE OF CONTENTS
| SUMMARY | 5 | |
| CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS | 6 | |
| RISK FACTORS | 9 | |
| THE OFFER | 11 | |
| 1. | GENERAL TERMS | 11 |
| 2. | PROCEDURE FOR TENDERING WARRANTS | 13 |
| 3. | BACKGROUND AND PURPOSE OF THE OFFER | 17 |
| 4. | PRICE RANGE OF SHARES | 19 |
| 5. | SOURCE AND AMOUNT OF FUNDS | 20 |
| 6. | FEES AND EXPENSES | 20 |
| 7. | TRANSACTIONS AND AGREEMENTS CONCERNING THE WARRANTS | 21 |
| 8. | FINANCIAL INFORMATION REGARDING THE COMPANY | 21 |
| 9. | EXTENSIONS; AMENDMENTS; CONDITIONS; TERMINATION; PLANS | 21 |
| 10. | MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES | 22 |
| 11. | ADDITIONAL INFORMATION; MISCELLANEOUS | 24 |
4
SUMMARY
The following summary is qualified in its entirety by the more detailed information appearing elsewhere in this Offer to Exchange. An investment in our Shares involves risks. You should carefully consider the information provided under the heading “Risk Factors.”
A. The Company - Zoomcar Holdings, Inc., a Delaware corporation. Our principal executive offices are located at Anjaneya Techno Park, No.147, 1st Floor, Kodihalli, Bangalore, India 560008.
B. The Eligible Warrants - As of January 22, 2026, the Company has outstanding the Eligible Warrants described above. Only the Eligible Warrants are eligible to be tendered for exchange in this Offer. By their terms, (i) the Common Warrants will expire on December 27, 2028, (ii) the Series A Warrants will expire on February 17, 2030, (iii) the Series B Warrants will expire once exercised in full, (iv) the Pre-Funded Warrants will expire once exercised in full, (v) the Bridge Placement Agent Warrants will expire on December 12, 2029, (vi) Placement Agent Warrants will expire on December 12, 2029, and (vii) Series A Placement Agent Warrants will expire on February 17, 2030.
C. Market Price of the Shares - Our Shares are listed/ on the OTCQB under the symbol “ZCAR”. On January 21, 2026, the last reported closing sales price for the Shares was $0.074222 per share.
D. The Offer - After the closing of the Offer, holders who have tendered Eligible Warrants will be entitled to receive Shares of Common Stock in accordance with the Exchange Ratios. The Exchange Ratios were selected by the Company in order to provide holders of Eligible Warrants with an incentive to exchange such Eligible Warrants. The “Offer Period” is the period commencing on January 23, 2026, and ending at 5:00 p.m., Eastern Time, on March 31, 2026, or such later date to which the Company may extend the Offer (the “Expiration Date”).
E. Reasons for the Offer - The purpose of the Offer is to (i) reduce the aggregate number of warrants outstanding and the dilutive “overhang” associated with the Eligible Warrants, (ii) simplify the Company’s capital structure, and (iii) support the Company’s financing and capital markets objectives, including by facilitating the Authorized Share Increase and related corporate actions. See Section 3.C., “Background and Purpose of the Offer—Purpose of the Offer.”
F. Expiration Date of Offer - The Expiration Date is 5:00 p.m., Eastern Time, on March 31, 2026, or such date to which we may extend the Offer. All Eligible Warrants and related paperwork must be received by the Exchange Agent by this time, as instructed herein. See Section 9, “Extensions; Amendments; Conditions; Termination; Plans.”
G. Lock-Up Requirement — As a condition to receiving Shares in the Offer, each participating holder will be required to execute and deliver a lock-up agreement pursuant to which 50% of the Shares received in the Offer will be subject to transfer restrictions until the date that is twelve (12) months after the Expiration Date (as it may be extended) and the remaining 50% of such Shares will be subject to transfer restrictions until the date that is eighteen (18) months after the Expiration Date (as it may be extended), subject to customary exceptions.
H. Withdrawal Rights - If you tender your Eligible Warrants and change your mind, you may withdraw your tendered Eligible Warrants at any time until the Expiration Date, as described in greater detail in Section 2 herein. See Section 2.B., “Withdrawal Rights.”
I. Participation by Officers and Directors - Certain members of the Company’s board of directors hold Eligible Warrants that are subject to the Offer. Based on information provided by the Company, John Clarke (Director) holds 9 Common Warrants, Swatick Majumdar (Director) holds 46 Common Warrants, and Uri Levine (Director) holds 84,907 Pre-Funded Warrants. Any Eligible Warrants held by directors or officers may be tendered in the Offer on the same terms and conditions as those applicable to all other eligible holders.
5
J. Conditions of the Offer - The Offer is subject to conditions, including that the Authorized Share Increase must be approved and effective, and that no action or event shall have occurred, no action shall have been taken, and no statute, rule, regulation, judgment, order, stay, decree or injunction shall have been promulgated, enacted, entered or enforced applicable to the Offer or the exchange of Eligible Warrants for Shares under the Offer that challenges the making of the Offer or would reasonably be expected to prohibit, prevent, restrict or delay consummation of, or would reasonably be expected to otherwise adversely affect in any material manner, the Offer. See Section 9.F., “Conditions of the Offer.”
K. Termination - We may terminate the Offer if the Conditions of the Offer are not satisfied prior to the Expiration Date. See Section 9, “Extensions; Amendments; Conditions; Termination.”
L. Fractional Shares - No scrip or fractional shares will be issued. Eligible Warrants may only be exchanged for whole Shares. Holders who would otherwise have been entitled to receive fractional Shares will, after aggregating all such fractional Shares of such holder, receive the number of Shares as rounded down to the nearest whole Share. See Section 1, “General Terms.”
M. Board of Directors’ Recommendation - Our Board of Directors has approved the Offer. However, none of the Company, its directors, officers or employees makes any recommendation as to whether to tender Eligible Warrants. You must make your own decision as to whether to tender some or all of your Eligible Warrants. See Section 1.C., “General Terms—Board Approval of the Offer; No Recommendation; Holder’s Own Decision.”
N. Solicitation Agent - The Company has not retained a solicitation agent for the exchange offer, and no commission or other remuneration will be paid directly or indirectly for soliciting tenders.
O. How to Tender Eligible Warrants - To tender your Eligible Warrants, you must complete the actions described herein under Section 2 before the Offer expires. You may also contact the Exchange Agent or your broker for assistance. See Section 2, “Procedure for Tendering Warrants.”
P. Certain Material U.S. Federal Tax Consequences - Holders are urged to consult their personal tax advisors concerning the tax consequences of an exchange pursuant to the Offer based on their particular circumstances. For a general discussion of certain tax considerations, see Section 10, “Material U.S. Federal Income Tax Consequences.”
Q. Further Information - Please direct questions or requests for assistance, or for additional copies of this Offer to Exchange, Letters of Transmittal and Consent or other materials, to the Exchange Agent or the Company at the contact information set forth under “Important Procedures” above and in Section 11, “Additional Information; Miscellaneous.”
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Offer to Exchange and the other documents that constitute the offer materials (collectively, the “Offer Materials”) may contain certain statements that may constitute forward-looking statements within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. This includes, without limitation, statements regarding expectations, hopes, beliefs, intentions, plans, prospects, financial results or strategies regarding the Company and the future held by our management team, as well as statements regarding the Offer, including the expected timing, terms, mechanics, conditions, and completion of the Offer, the satisfaction of the conditions to the Offer (including the Authorized Share Increase), the expected number of Eligible Warrants tendered, the expected number of shares of Common Stock to be issued in the Offer, the expected impact of the Offer on our capital structure, the expected effect of the Offer on the “warrant overhang” and potential dilution, our plans to register shares (if any) in the future, and other statements that are not statements of historical fact. These statements constitute projections, forecasts and forward-looking statements, and are not guarantees of performance.
6
Forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts. When used in these Offer Materials, forward-looking statements may be identified by the use of words such as “estimate,” “continue,” “could,” “may,” “might,” “possible,” “predict,” “should,” “would,” “plan,” “project,” “forecast,” “intend,” “will,” “expect,” “anticipate,” “believe,” “seek,” “target,” “designed to,” “aim,” “potential,” or other similar expressions that predict or indicate future events or trends or that are not statements of historical facts. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements.
We caution readers that these forward-looking statements are subject to risks and uncertainties, many of which are difficult to predict and many of which are beyond our control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. The following factors, among others, could cause actual results and the timing of events to differ materially from the anticipated results or other expectations expressed in the forward-looking statements contained in these Offer Materials:
| ● | our ability to satisfy the conditions to the Offer, including obtaining stockholder approval of the Authorized Share Increase and the filing and effectiveness of the related certificate of amendment with the Secretary of State of the State of Delaware; |
| ● | the risk that the Offer is not completed, is delayed, is extended, is amended, or is terminated, including due to failure to satisfy any condition to the Offer, applicable legal or regulatory considerations, or other developments; |
| ● | the risk that a sufficient number of Eligible Warrants are not tendered (and, with respect to any series where consents are solicited, the risk that the requisite holder consents are not obtained, if applicable); |
| ● | the market price of our Common Stock and its volatility, including the possibility that the market price of our Common Stock declines during the Offer period or after completion of the Offer; |
| ● | the dilutive effect of the issuance of a substantial number of shares of Common Stock in the Offer, which could adversely affect the market price of our Common Stock; |
| ● | the risk that the shares of Common Stock issued in the Offer will be “restricted securities,” will bear appropriate restrictive legends, and may not be freely resold absent registration or an applicable exemption from registration; |
| ● | our ability to maintain the quotation of our Common Stock on the OTCQB (or other trading market, as applicable) and to satisfy applicable listing or quotation standards; |
| ● | our ability to execute our anticipated business plans and strategy, particularly in light of our current liquidity and capital resources; |
| ● | our ability to obtain additional capital, which may be necessary to continue our business and operations; |
| ● | our limited operating history under our current business model and history of net losses; |
7
| ● | our reliance on key technology providers and payment processors facilitating payments to and by our customers; |
| ● | unfavorable interpretations of laws or regulations or changes in applicable laws or regulations; |
| ● | the possibility that we may be adversely affected by other economic, business, regulatory and/or competitive factors; and |
| ● | other risks and uncertainties described in our filings with the Securities and Exchange Commission (the “SEC”), including those under the section entitled “Risk Factors,” and the risks described in the “Risk Factors” section of these Offer Materials. |
If any of these risks materialize or any of our assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that we presently do not know or that we currently believe are immaterial that could also cause actual results to differ materially from those contained in the forward-looking statements.
Forward-looking statements reflect our expectations, plans or forecasts of future events and views as of the date of these Offer Materials (or, with respect to documents incorporated by reference, the date of the filing of such documents). We anticipate that subsequent events and developments may cause our assessments to change. However, except as required by law, we specifically disclaim any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing our assessments as of any date subsequent to the date of these Offer Materials. Accordingly, undue reliance should not be placed upon the forward-looking statements.
You should not rely on forward-looking statements as predictions of future events. We have based the forward-looking statements contained in these Offer Materials primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition, operating results and the outcome of the Offer. We operate in a competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in these Offer Materials. The results, events and circumstances reflected in the forward-looking statements may not be achieved or occur, and actual results, events or circumstances could differ materially from those described in the forward-looking statements.
In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based on information available to us as of the date of these Offer Materials. While we believe that information provides a reasonable basis for these statements, that information may be limited or incomplete. Our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely on these statements.
The forward-looking statements made in these Offer Materials relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date of these Offer Materials or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments.
8
RISK FACTORS
An investment in our Shares involves a high degree of risk. You should carefully consider each of the risks described below, together with all of the other information set forth elsewhere in this Offer to Exchange and the risks and other information described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and our subsequently filed quarterly reports on Form 10-Q and current reports on Form 8-K. Additional risks and uncertainties not presently known to the Company or that the Company currently deems immaterial also may impair our business operations. If any of the matters identified as potential risks materialize, our business could be harmed. In that event, the trading price of our Common Stock could decline.
There is no guarantee that your decision whether to tender your Eligible Warrants in the Offer will put you in a better future economic position.
We can give no assurance as to the price at which a stockholder may be able to sell our Common Stock in the future following the completion of the Offer. If you choose to tender your Eligible Warrants in the Offer, certain future events may cause an increase in our Common Stock price and may result in receiving fewer shares of Common Stock now than you might receive from future warrant exercises had you not agreed to exchange your Eligible Warrants. Similarly, if you do not tender your Eligible Warrants in the Offer, you will continue to bear the risk of ownership of your Eligible Warrants after the closing of the Offer, including the risk that the Eligible Warrants may expire “out-of-the-money” according to their terms. You should consult your own individual tax and/or financial advisor for assistance on how this may affect your individual situation.
There is no assurance that the Offer will be successful.
There is no assurance that a sufficient number of Eligible Warrants will be tendered or that the conditions to the Offer (including the Authorized Share Increase) will be satisfied. Moreover, there is no assurance that the price of our Common Stock will increase. Eliminating or significantly reducing warrant “overhang” will not generate any capital for our Company.
If the holders of Eligible Warrants accept the Offer, we will issue them additional shares of Common Stock, which will dilute existing stockholders.
The issuance of additional Common Stock upon the exchange of tendered Eligible Warrants will dilute the percentage ownership interests in the Company of other stockholders and may adversely affect the market price of our Common Stock.
The market price of our Common Stock will fluctuate, and it may adversely affect Eligible Warrant holders who tender their Eligible Warrants for Common Stock.
The market price of our Shares may fluctuate between the date the Offer is commenced, the Expiration Date of the Offer and the date on which Shares are issued to tendering Eligible Warrant holders. Accordingly, the market price of Shares upon settlement of the Offer could be less than the price of our Common Stock when Eligible Warrants were tendered. The Company does not intend to re-adjust the Exchange Ratios based on any fluctuation in the price of our Shares.
The exchange of Eligible Warrants for shares of Common Stock will result in the issuance of a substantial number of shares and will significantly dilute existing stockholders, and may adversely affect the market price of our Common Stock.
If we complete the Offer, we expect to issue a substantial number of shares of Common Stock in exchange for Eligible Warrants that are tendered and accepted. The issuance of these shares will dilute the ownership interests of our existing stockholders and may depress the market price of our Common Stock. In addition, the increased number of outstanding shares may increase the number of shares eligible for resale in the public market over time (including pursuant to Rule 144 or any future registration statement we may file), which could further adversely affect the market price of our Common Stock.
Even if we do not complete the Offer for all classes of Eligible Warrants, to the extent any Eligible Warrants remain outstanding and are later exercised (if and to the extent exercisable) or otherwise result in the issuance of shares, additional shares may be issued in the future, resulting in further dilution.
If the Authorized Share Increase is not approved and effective, the Company may extend or terminate the Offer.
The Offer is conditioned upon, among other things, approval by our stockholders of an amendment to our amended and restated certificate of incorporation to increase the number of authorized shares of Common Stock and the filing and effectiveness of such amendment with the Secretary of State of the State of Delaware. If stockholder approval is not obtained, if the amendment is not filed, or if it does not become effective within the required timeframe, we may extend, amend or terminate the Offer. In any such event, Eligible Warrants that have been tendered and not accepted for exchange will be returned to tendering holders, and holders will not receive any shares of Common Stock in the Offer.
Shares issued in the Offer are expected to be restricted securities and may not be freely resold.
The Shares issued in the Offer are expected to be issued as “restricted securities” and will bear an appropriate legend. Even if you are entitled to “tack” your holding period for purposes of Rule 144, you may be unable to resell the Shares when you desire, or at all, absent an exemption from registration or an effective registration statement.
9
Shares you receive in the Offer will be subject to a contractual lock-up, which will further restrict your ability to transfer such Shares for up to eighteen (18) months after the Expiration Date.
If you participate in the Offer, you will be required to execute and deliver the Lock-Up Agreement as a condition to receiving Shares. Under the Lock-Up Agreement, 50% of the Shares you receive in the Offer will be subject to transfer restrictions until the date that is twelve (12) months after the Expiration Date (as it may be extended) and the remaining 50% of such Shares will be subject to transfer restrictions until the date that is eighteen (18) months after the Expiration Date (as it may be extended), subject to customary exceptions. As a result, even if an exemption from registration (including Rule 144) would otherwise be available, the Lock-Up Agreement will limit your ability to sell, transfer, pledge, hedge or otherwise dispose of the Shares during the applicable lock-up periods, which may reduce the liquidity and value of the Shares you receive.
We may not receive sufficient consents from holders of the Series A Warrants and/or Series B Warrants to implement the Offer as contemplated for those warrants.
The Series A Warrants and Series B Warrants are governed by warrant instruments that permit certain amendments or modifications to be approved with the consent of holders of a majority in interest of the applicable series. In connection with the Offer, we are soliciting such consents from holders of the Series A Warrants and Series B Warrants in order to facilitate the exchange of those warrants for shares of our Common Stock pursuant to the Offer. If we do not obtain the requisite consents for a series, the Offer with respect to that series may be delayed, amended, extended or terminated, and we may be unable to effect the exchange of that series of warrants on the terms described in these Offer Materials.
If the Offer is completed with respect to one or more classes of Eligible Warrants but not others, our capital structure may remain complex, the potential dilutive overhang associated with the Eligible Warrants may not be reduced to the extent anticipated, and the market price of our Common Stock may be adversely affected.
We have not obtained any third-party determination or fairness opinion that the Offer is fair to holders of Eligible Warrants.
None of our board of directors, officers or employees makes any recommendation as to whether you should tender any Eligible Warrants in the Offer. We have not retained, and do not intend to retain, any unaffiliated representative, financial advisor or investment bank to act on behalf of holders of Eligible Warrants for purposes of negotiating the Offer or preparing a report or opinion concerning the fairness of the Offer or the adequacy of the exchange ratios from a financial point of view. Accordingly, you must make your own independent decision regarding your participation in the Offer, including an evaluation of the exchange ratios and the risks associated with receiving shares of Common Stock in exchange for Eligible Warrants.
There is no guarantee that tendering your Eligible Warrants in the Offer will put you in a better economic position.
We can give no assurance as to the market price of our Common Stock in the future. If you choose to tender some or all of your Eligible Warrants in the Offer, future events may cause an increase in the market price of our Common Stock or changes in market conditions that may result in a lower value realized by participating in the Offer than you might have realized if you did not tender your Eligible Warrants. Similarly, if you do not tender your Eligible Warrants in the Offer, there can be no assurance that you will be able to sell your Eligible Warrants (if a market exists), exercise them (if and when exercisable) or otherwise realize value from them in the future.
In addition, because the Offer is conditioned upon, among other things, the Authorized Share Increase, there can be no assurance that the Offer will be completed, and tendering holders may experience delays or uncertainty regarding settlement.
10
The exchange ratios are fixed and the market price of our Common Stock may fluctuate, and the value of the Common Stock you receive may be less than the value you ascribe to your Eligible Warrants at the time you tender them.
The number of shares of Common Stock offered in the Offer for each Eligible Warrant accepted for exchange is fixed as described in these Offer Materials and will fluctuate in value based on changes in the market price of our Common Stock. Accordingly, the market price of our Common Stock when we issue shares to you in exchange for your Eligible Warrants could be less than the market price of our Common Stock (or the value you attribute to your Eligible Warrants) at the time you tender your Eligible Warrants. The market price of our Common Stock could also continue to fluctuate and be subject to volatility during the period between the date you tender Eligible Warrants and the date we accept Eligible Warrants for exchange and deliver shares, including during any extension of the Offer period.
No rulings or opinions have been received as to the tax consequences of the Offer to holders of Eligible Warrants.
The tax consequences that will result to an Eligible Warrant holder that participates in the Offer are not well defined by the existing authorities. No ruling of any governmental authority and no opinion of counsel has been issued or rendered on these matters. Eligible Warrant holders must therefore rely on the advice of their own tax advisors in assessing these matters. For a general discussion of certain tax considerations, see Section 10, “Material U.S. Federal Income Tax Consequences.”
THE OFFER
Risks of Participating In the Offer
Participation in the Offer involves a number of risks, including, but not limited to, the risks identified in “Risk Factors”
above. Holders should carefully consider these risks and are urged to speak with their personal financial, investment and/or tax advisors
as necessary before deciding whether to participate in the Offer. In addition, the Company strongly encourages you to read this Offer
to Exchange in its entirety and review the documents referred to in “Risk Factors,” above as well, including the risks and
other information described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and our subsequently filed
quarterly reports on Form 10-Q and current reports on Form 8-K.
1. GENERAL TERMS
Subject to the terms and conditions of the Offer, the Company is making an offer to holders of the Eligible Warrants to tender their Eligible Warrants in exchange for Shares of our Common Stock. Under this Offer to Exchange, the Eligible Warrant holders will be entitled to receive Shares in accordance with the Exchange Ratios. The “Offer Period” is the period commencing on January 23, 2026 and ending at 5:00 p.m., Eastern Time, on March 31, 2026, or such later date to which the Company may extend the Offer (the “Expiration Date”).
As a condition to the issuance of Shares in the Offer, each holder whose Eligible Warrants are tendered and accepted for exchange will be required to execute and deliver a lock-up agreement in favor of the Company (the “Lock-Up Agreement”) pursuant to which (i) 50% of the Shares issued to such holder in the Offer may not be sold, transferred, pledged, hedged, or otherwise disposed of until the date that is twelve (12) months after the Expiration Date (as it may be extended), and (ii) the remaining 50% of such Shares may not be sold, transferred, pledged, hedged, or otherwise disposed of until the date that is eighteen (18) months after the Expiration Date (as it may be extended), in each case subject to customary exceptions as set forth in the Lock-Up Agreement. The Shares issued in the Offer are expected to bear an appropriate restrictive legend, and the Company may impose stop-transfer instructions to its transfer agent to enforce the Lock-Up Agreement.
11
This Offer is not an “all or none” offer. Holders may tender all or any portion of the Eligible Warrants they hold of a particular class, subject to the procedures described herein and in the applicable Letters of Transmittal and Consent. Tendering Eligible Warrants is voluntary. Eligible Warrants that are not tendered will remain outstanding in accordance with their existing terms, subject, in the case of the Series A Warrants and Series B Warrants, to any amendments or supplements that become effective upon receipt of the requisite holder consents as described below.
Warrants may only be exchanged for whole Shares. No scrip or fractional shares will be issued. Holders of Eligible Warrants who would otherwise have been entitled to receive fractional Shares will, after aggregating all such fractional Shares of such holder, receive the number of Shares as rounded down to the nearest whole Share.
If you elect to tender Eligible Warrants in response to the Offer, please follow the instructions in this Offer to Exchange and the related documents, including the Letter of Transmittal and Consent applicable to the class of Eligible Warrants you are tendering.
If you tender your Eligible Warrants, you may withdraw your tendered Eligible Warrants before the Expiration Date and retain them on their terms by following the instructions herein.
This Offer to Exchange is made pursuant to the exemption from registration provided by Section 3(a)(9) of the Securities Act.
A. Period of Offer
The Offer will only be open for a period beginning on January 23, 2026, and ending on the Expiration Date. The Company expressly reserves the right, in its sole discretion, at any time or from time to time, to extend the period of time during which the Offer is open. There can be no assurance, however, that the Company will exercise its right to extend the Offer.
B. Partial Tender Permitted
Unlike an “all or none” exchange offer, a holder may tender all or any portion of the Eligible Warrants it holds of a particular class. A holder’s tender will be effective only as to the number of Eligible Warrants properly tendered and accepted. The Company reserves the right to modify the tender procedures to the extent permitted by applicable law, including to require minimum tender thresholds for any class of Eligible Warrants, in which case the Company will provide notice to holders and extend the Offer as required by applicable law.
12
C. Board Approval of the Offer; No Recommendation; Holder’s Own Decision
THE COMPANY’S BOARD OF DIRECTORS HAS APPROVED THE OFFER. HOWEVER, NONE OF THE COMPANY, ITS DIRECTORS, OFFICERS OR EMPLOYEES MAKES ANY RECOMMENDATION AS TO WHETHER TO TENDER ELIGIBLE WARRANTS. EACH HOLDER OF AN ELIGIBLE WARRANT MUST MAKE HIS, HER OR ITS OWN DECISION AS TO WHETHER TO TENDER SOME OR ALL OF HIS, HER OR ITS ELIGIBLE WARRANTS.
D. Extensions of the Offer
The Company expressly reserves the right, in its sole discretion, and at any time or from time to time, to extend the period of time during which the Offer is open. There can be no assurance, however, that the Company will exercise its right to extend the Offer. If the Company extends the Offer, it will give notice of such extension by press release or other public announcement no later than 9:00 a.m., Eastern Time, on the next business day after the previously scheduled Expiration Date of the Offer.
2. PROCEDURE FOR TENDERING WARRANTS
A. Procedures for Tendering Warrants
You do not have to participate in the Offer. If you decide not to participate in the Offer, you do not need to do anything, and your Eligible Warrants will remain outstanding until they expire or are exercised in accordance with their terms (subject, in the case of Series A Warrants and Series B Warrants, to any amendments or supplements that become effective upon receipt of the requisite holder consents).
To participate in the Offer, you must properly complete, sign and date the Letter of Transmittal and Consent and mail or otherwise deliver to the Exchange Agent the Letter of Transmittal and Consent and any other required documents so that the Exchange Agent receives them no later than 5:00 p.m., Eastern Time, on the Expiration Date (or such later date and time if we extend the Offer), at the address set forth in the applicable Letter of Transmittal and Consent.
The Letter of Transmittal and Consent must be executed by the record holder of the tendered Eligible Warrants. However, if the signature is by a trustee, executor, administrator, guardian, attorney-in-fact, officer of a corporation or another person acting in a fiduciary or representative capacity, the signer’s full title and proper evidence of the authority of such person to act in such capacity must be indicated on the Letter of Transmittal and Consent.
If you do not submit a properly completed Letter of Transmittal and Consent for your Eligible Warrants prior to the Expiration Date of the Offer, or if you submit an incomplete or incorrectly completed Letter of Transmittal and Consent, you will be considered to have rejected the Offer to Exchange with respect to such Eligible Warrants.
THE METHOD OF DELIVERY OF ELIGIBLE WARRANTS, THE APPLICABLE LETTER OF TRANSMITTAL AND CONSENT AND ALL OTHER REQUIRED DOCUMENTS TO THE EXCHANGE AGENT IS AT THE ELECTION, EXPENSE AND RISK OF THE HOLDER. IT IS RECOMMENDED THAT HOLDERS ALLOW SUFFICIENT TIME TO ASSURE DELIVERY TO THE EXCHANGE AGENT BEFORE THE EXPIRATION DATE.
13
B. Withdrawal Rights
You may change your election and withdraw your tendered Eligible Warrants only if you properly complete, sign and date the Notice of Withdrawal included with the Offer and mail, email or otherwise deliver the Notice of Withdrawal to the Exchange Agent so that it is received no later than 5:00 p.m., Eastern Time, on the Expiration Date. You may also withdraw your tendered Eligible Warrants pursuant to Rule 13e-4(f)(2)(ii) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), if they have not been accepted by us for exchange within 40 business days from the commencement of the Offer. [ .]
The Notice of Withdrawal must be executed by the record holder of the Eligible Warrants to be withdrawn. However, if the signature is by a trustee, executor, administrator, guardian, attorney-in-fact, officer of a corporation or another person acting in a fiduciary or representative capacity, the signer’s full title and proper evidence of the authority of such person to act in such capacity must be indicated on the Notice of Withdrawal.
Withdrawals of Eligible Warrants may not be rescinded. Any Eligible Warrants properly withdrawn will thereafter be deemed not to have been validly tendered for purposes of the Offer. However, withdrawn Eligible Warrants may be re-tendered by following the procedures described in the Offer at any time prior to the Expiration Date.
ALL QUESTIONS AS TO THE FORM AND VALIDITY (INCLUDING TIME OF RECEIPT) OF ANY NOTICE OF WITHDRAWAL WILL BE DETERMINED BY THE COMPANY, IN ITS REASONABLE DISCRETION, WHOSE DETERMINATION WILL BE FINAL AND BINDING. NONE OF THE COMPANY OR ANY OTHER PERSON WILL BE UNDER ANY DUTY TO GIVE NOTIFICATION OF ANY DEFECTS OR IRREGULARITIES IN ANY NOTICE OF WITHDRAWAL OR INCUR ANY LIABILITY FOR FAILURE TO GIVE ANY SUCH NOTIFICATION.
C. Determination of Validity; Rejection of Eligible Warrants; Waiver of Defects; No Obligation to Give Notice of Defects
We will determine, in our discretion, all questions as to form, validity, including time of receipt, eligibility and acceptance of any tender of Eligible Warrants or withdrawal of tendered Eligible Warrants. Our determination of these matters will be final and binding on all parties. We may reject any or all tenders of or withdrawals of tendered Eligible Warrants that we determine are not in an appropriate form or that we determine are unlawful to accept or not timely made. Otherwise, we expect to accept all properly and timely tendered Eligible Warrants which are not validly withdrawn. We may waive, as to all Eligible Warrant holders, any defect or irregularity in any tender with respect to any particular Eligible Warrant, to the extent permitted by applicable law. No tender of Eligible Warrants or withdrawal of tendered Eligible Warrants will be deemed to have been properly made until all defects or irregularities have been cured by the tendering Eligible Warrant holder or waived by us. NEITHER WE NOR ANY OTHER PERSON IS OBLIGATED TO GIVE NOTICE OF ANY DEFECTS OR IRREGULARITIES IN TENDERS OR WITHDRAWALS, AND NO ONE WILL BE LIABLE FOR FAILING TO GIVE NOTICE OF ANY DEFECTS OR IRREGULARITIES.
14
D. Acceptance of Eligible Warrants; Issuance of Common Stock
The Offer is scheduled to expire at 5:00 p.m., Eastern Time, on the Expiration Date, March 31, 2026 (subject to our right to extend the Offer). Upon the terms and subject to the conditions of the Offer, including the Authorized Share Increase, and the execution and delivery of the Lock-Up Agreement by participating holders, we expect, upon the expiration of the Offer, to (i) accept for exchange Eligible Warrants properly tendered and not validly withdrawn pursuant to the Offer, and (ii) issue Shares of Common Stock in exchange for tendered Eligible Warrants pursuant to the Offer. No participating holder will receive Shares in the Offer unless and until such holder has executed and delivered the Lock-Up Agreement in accordance with the procedures described in these Offer Materials.
If you elect to tender your Eligible Warrants pursuant to the Offer and you do so according to the procedures described herein, you will have accepted the Offer. Our acceptance of your outstanding Eligible Warrants for tender in the Offer will form a binding agreement between you and us upon the terms and subject to the conditions of the Offer upon the expiration of the Offer.
If you elect not to participate in the Offer, your Eligible Warrants will remain outstanding until they expire or are exercised by their original terms (subject, in the case of Series A Warrants and Series B Warrants, to any amendments or supplements that become effective upon receipt of the requisite holder consents).
Penny Stock Considerations
Our Common Stock is a “penny stock” as defined in Rule 3a51-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The SEC’s penny stock rules generally apply to equity securities that have a market price of less than $5.00 per share (subject to certain limited exceptions). The penny stock rules impose additional sales practice requirements on broker-dealers that sell penny stocks to persons other than established customers and “accredited investors” (as defined in Regulation D under the Securities Act).
In general, broker-dealers must (among other things): (i) deliver a standardized risk disclosure document prepared by the SEC that provides information about penny stocks and the penny stock market; (ii) provide the customer with current bid and offer quotations for the penny stock, the compensation payable to the broker-dealer and its representative in connection with the transaction, and monthly account statements showing the market value of each penny stock held in the customer’s account; (iii) make a special written determination that the penny stock is a suitable investment for the purchaser and obtain the purchaser’s written agreement to the transaction; and (iv) provide certain additional disclosures prior to effecting the transaction. These requirements can reduce the level of trading activity in penny stocks and may make it more difficult to sell shares of our Common Stock in the secondary market.
As a result of the penny stock rules, holders of shares of Common Stock issued in the Offer may experience reduced liquidity, increased transaction costs, greater price volatility, and difficulty reselling their shares at a time or price they desire. In addition, the market for our Common Stock may be limited, and it may be difficult for broker-dealers to recommend or execute transactions in our Common Stock, which could adversely affect the market price of our Common Stock and your ability to dispose of shares received in the Offer.
If you tender Eligible Warrants pursuant to the Offer, you will receive legended Shares, and you will generally be entitled to “tack” your holding period of the Eligible Warrants so tendered for purposes of Rule 144 under the Securities Act, subject to the facts and circumstances of your holding and compliance with Rule 144.
15
E. Extension of the Offer; Termination; Amendment
Although we do not currently intend to do so, we may, from time to time, at our discretion, extend the Offer at any time as provided above. If we extend the Offer, we will continue to accept validly tendered Eligible Warrants until the new Expiration Date.
We also expressly reserve the right, in our reasonable judgment, prior to the Expiration Date, to terminate or amend the Offer and to postpone our acceptance of any tendered Eligible Warrant upon the occurrence of any of the conditions specified below under “The Offer—Conditions of the Offer.”
Extension or amendments to, or a termination of, the Offer may be made at any time and from time to time by an announcement. In the case of an extension, the announcement must be issued no later than 9:00 a.m., Eastern Time, on the next business day after the last previously scheduled or announced Expiration Date. Any announcement made pursuant to the Offer will be disseminated promptly to holders of Eligible Warrants in a manner reasonably designed to inform such holders of such amendment. Without limiting the manner in which we may choose to make an announcement, except as required by applicable law, we have no obligation to publish, advertise or otherwise communicate any such announcement other than by issuing a press release.
If we materially change the terms of the Offer or the information concerning the Offer, or if we waive a material condition of the Offer, we will extend the Offer to the extent required by Rules 13e-4(d)(2), 13e-4(e)(3), and 13e-4(f)(1)(ii) under the Exchange Act. These rules require that the minimum period during which an offer must remain open following material changes in the terms of the Offer or information concerning the offer, other than a change in price or a change in percentage of securities sought, will depend on the facts and circumstances, including the relative materiality of such terms or information.
F. Conditions of the Offer
The Offer is subject to the following conditions: no action or event shall have occurred, no action shall have been taken, and no statute, rule, regulation, judgment, order, stay, decree or injunction shall have been promulgated, enacted, entered or enforced applicable to the Offer or the exchange of Eligible Warrants for Shares under the Offer by or before any court or governmental regulatory or administrative agency, authority or tribunal of competent jurisdiction, including, without limitation, taxing authorities, that challenges the making of the Offer or the exchange of Eligible Warrants for Shares under the Offer or would reasonably be expected to, directly or indirectly, prohibit, prevent, restrict or delay consummation of, or would reasonably be expected to otherwise adversely affect in any material manner, the Offer or the exchange of Eligible Warrants for Shares under the Offer.
The Offer is also subject to the condition that the Authorized Share Increase must be approved by the Company’s stockholders, and that the related certificate of amendment must be filed and become effective. In addition, with respect to the Series A Warrants and Series B Warrants, the Offer may be conditioned upon obtaining the requisite holder consents to approve any amendments or supplements to the governing warrant instruments necessary to facilitate the exchange contemplated by this Offer, as described in the applicable Letter of Transmittal and Consent and the Offer Materials.
16
We may terminate the Offer if the Conditions of the Offer are not satisfied prior to the Expiration Date. In the event that we terminate the Offer, all Eligible Warrants tendered by an Eligible Warrant holder in connection with the Offer shall be returned to such Eligible Warrant holder, and the Eligible Warrants will continue to remain outstanding in accordance with their terms.
3. BACKGROUND AND PURPOSE OF THE OFFER
A. Information Concerning Zoomcar Holdings, Inc.
Zoomcar Holdings, Inc. (the “Company,” “Zoomcar,” “we,” “us” or “our”) is an emerging market-focused online car sharing marketplace headquartered in Bangalore, India. Our mission is to transform the urban mobility landscape across emerging market countries by connecting individuals with short- and medium-term transportation needs with vehicle owners through the convenience of our scalable digital platform. Through our marketplace, vehicle owners (“Hosts”) list their cars for rent and individuals seeking temporary access to a vehicle (“Guests”) can browse, book and use those vehicles at mutually convenient locations, with payments and key trip functionality facilitated through our mobile applications and website.
Founded in 2012, Zoomcar’s platform is designed to address transportation challenges in emerging markets, where cost-efficient and convenient mobility options may be limited and the cost of car ownership can be high relative to average income levels. Guests use our platform to search across a range of vehicle makes, models and price points and book vehicles for leisure, work or other short- to medium-term use cases. Hosts can monetize underutilized vehicles by making them available to Guests and can use platform tools to manage listings, availability, and pricing.
Our technology is central to our business model. We employ data-driven tools, including algorithmic search and ranking functionality, to support vehicle discovery and personalization, and we utilize platform features intended to promote trust and accountability, including Host and Guest ratings and reviews. We also deploy a software-enabled keyless entry solution across the majority of Host vehicles to enable contactless vehicle access via smartphone and use GPS-enabled tracking functionality to support trip management and related operational needs.
As of March 31, 2025, we had approximately 40,221 registered Host vehicles and approximately 4 million active Guests (defined as Guests who have searched our platform for vehicles or bookings within the preceding 12-month period). We have operated in over 94 cities across India and, following prior expansion efforts outside India, we have ceased operations in certain non-India markets to focus our engineering and financial resources on India.
The Company is a Delaware corporation and remains a reporting company under the Securities Exchange Act of 1934, as amended. Following the delisting of our common stock from The Nasdaq Stock Market, our common stock and public warrants began trading on the OTC Markets Group platform under the symbols “ZCAR” and “ZCARW,” respectively, and we have applied for trading on the OTCQX Best Market for our common stock and on the OTCQB Venture Market for our public warrants.
Our principal executive offices are located at Anjaneya Techno Park, No.147, 1st Floor, Kodihalli, Bangalore, Karnataka India 560008. Our telephone number is: +91 80488 21871.
17
B. Establishment of Offer Terms; Approval of the Offer
The Company’s Board of Directors has approved the terms of the Offer, including the Exchange Ratios, but is not recommending whether you should or should not tender your Eligible Warrants, nor passing upon the fairness of the Exchange Ratios. The Board set the Exchange Ratios to provide holders of Eligible Warrants with an incentive to exchange the Eligible Warrants and to support the Company’s capital structure objectives.
C. Purpose of the Offer
The Company is pursuing financing, restructuring and capital markets objectives, including, without limitation, the completion of the Company’s ongoing financing transactions and potential listing or uplisting initiatives. The Eligible Warrants represent a significant potential dilutive overhang and, in certain cases, contain provisions that may impede the Company’s ability to engage the capital markets effectively. As such, the Company believes that the Eligible Warrants may inhibit its ability to execute its strategic objectives and create value.
Secondarily, the purpose of the Offer is to simplify the Company’s capital structure by retiring and cancelling Eligible Warrants exchanged in the Offer.
The Offer is not made pursuant to a plan to periodically increase a securityholder’s proportionate interest in the assets or earnings and profits of the Company. Eligible Warrants acquired pursuant to the exchange will be retired and cancelled.
D. Interests of Directors and Officers
The names of the executive officers and directors of the Company are set forth below. The business address for each such person is: c/o Zoomcar Holdings, Inc. Anjaneya Techno Park, No.147, 1st Floor, Kodihalli, Bangalore, Karnataka India 560008, and the telephone number for each such person is. Certain members of the Company’s board of directors hold Eligible Warrants that are subject to the Offer. Based on information provided by the Company, John Clarke (Director) holds 9 Common Warrants, Swatick Majumdar (Director) holds 46 Common Warrants, and Uri Levine (Director) holds 84,907 Pre-Funded Warrants. Any Eligible Warrants held by directors or officers may be tendered in the Offer on the same terms and conditions as those applicable to all other eligible holders.
| Name | Position | |
| Uri Levine | Director | |
| Mohan Ananda | Director | |
| Evelyn D’An | Director | |
| Swatick Majumdar | Director | |
| John Clarke | Director | |
| Deepankar Tiwari | Chief Executive Officer | |
| Sachin Gupta | Chief Financial Officer |
18
E. Plans or Proposals
Except as set forth below, there are no present plans or proposals by the Company that relate to or would result in: (a) an extraordinary corporate transaction, such as a merger, reorganization or liquidation involving the Company or any of its subsidiaries; (b) a purchase, sale or transfer of a material amount of assets of the Company or any of its subsidiaries; (c) any change in the present Board of Directors or management of the Company including, but not limited to, any plans or proposals to change the number or the term of directors, to fill any existing vacancy on the Board or to change any material term of the employment contract of any executive officer; (d) any material change in the present dividend rate or policy, or indebtedness or capitalization of the Company; (e) any other material change in the Company’s corporate structure or business; (f) changes in the Company’s certificate of incorporation or bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Company by any person; (g) a class of equity security of the Company becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Exchange Act; or (h) the suspension of the issuer’s obligation to file reports pursuant to Section 15(d) of the Exchange Act.
The following are exceptions to the foregoing statement: (i) the exchange of Eligible Warrants pursuant to the Offer will result in the issuance of Shares in accordance with the Exchange Ratios; (ii) the Company expects to seek stockholder approval of the Authorized Share Increase and to file a preliminary proxy statement and definitive proxy statement with the SEC in connection therewith; and (iii) contemporaneously with the commencement of the Offer, the Company expects to launch a bridge financing transaction of up to $5,000,000 of units (the “Bridge Financing”), with each unit consisting of one share of the Company’s Series A convertible preferred stock, par value $0.0001 per share (the “Series A Preferred”), and one warrant to purchase shares of Common Stock (the “Bridge Warrant”). Each share of Series A Preferred will have a stated value of $1,000 and will be convertible into shares of Common Stock at a conversion price of $0.05 per share (subject to adjustment as provided in the applicable governing documents), and each Bridge Warrant will be exercisable for shares of Common Stock at an exercise price of $0.0625 per share (subject to adjustment as provided in the applicable governing documents). In addition, the Company is contemplating an uplisting transaction and may pursue an application to list its securities on a national securities exchange, as well as related capital markets and corporate transactions, although there can be no assurance as to the timing or completion of any such uplisting or related transaction.
4. PRICE RANGE OF SHARES
Our Shares are listed on the OTCQB under the symbol “ZCAR”. On January 21, 2026, the last reported closing sales price for the Shares was $0.074222. Our Eligible Warrants are not publicly traded.
The Company recommends that holders obtain current market quotations for the Common Stock, among other factors, before deciding whether or not to tender their Eligible Warrants.
19
The high and low closing sales
price per share of the Company’s common stock for each quarter during the last three (3) fiscal years is set forth below:
Fiscal Year 2025 (Unaudited)
| Quarter (Period) | Low Sale Price | High Sale Price | ||||||
| First Quarter (April 1 – June 30) | $ | 0.4840 | $ | 18.00 | ||||
| Second Quarter (July 1 – September 30) | $ | 0.2850 | $ | 0.778 | ||||
| Third Quarter (October 1 – December 31) | $ | 0.0562 | $ | 0.32 | ||||
| Fourth Quarter (January 1 – March 31) | $ | 0.060 | $ | 0.079 | ||||
Fiscal Year 2024
| Quarter (Period) | Low Sale Price | High Sale Price | ||||||
| First Quarter (April 1 – June 30) | $ | 260 | $ | 1260 | ||||
| Second Quarter (July 1 – September 30) | $ | 204 | $ | 530 | ||||
| Third Quarter (October 1 – December 31) | $ | 25 | $ | 320.8 | ||||
| Fourth Quarter (January 1 – March 31) | $ | 4.03 | $ | 46 | ||||
Fiscal Year 2023
| Quarter (Period) | Low Sale Price | High Sale Price | ||||||
| First Quarter (April 1 – June 30) | $ | 21,140 | $ | 23,180 | ||||
| Second Quarter (July 1 – September 30) | $ | [21,800] | $ | 22,580 | ||||
| Third Quarter (October 1 – December 31) | $ | [5,600] | $ | 29,500 | ||||
| Fourth Quarter (January 1 – March 31) | $ | 1,124 | $ | 15,220 | ||||
The foregoing table sets forth the reported high and low sale prices of the Company’s Common Stock for the periods indicated, based on quotations for the Common Stock on the OTCQB under the symbol “ZCAR”. Prices reflect inter-dealer quotations, without retail mark-up, mark-down or commission, and may not represent actual transactions. The Eligible Warrants are not traded on any market.
5. SOURCE AND AMOUNT OF FUNDS
Because this transaction is an offer to holders to exchange their existing Eligible Warrants for Shares, there is no source of funds to disclose, as there is no cash consideration being paid by the Company to those tendering Eligible Warrants. The Company will use funds on hand to pay any incidental expenses.
6. FEES AND EXPENSES
The Company has not retained a solicitation agent for the exchange offer. We will use our existing funds to pay expenses associated with the Offer. We will not receive any proceeds from this Offer. The Company has appointed Vinyl Equity, Inc. as the Exchange Agent to perform ministerial and administrative functions in connection with the Offer. The Exchange Agent will not be compensated for soliciting tenders, and any compensation payable to the Exchange Agent will not be based on the number of Eligible Warrants tendered or exchanged.
20
7. TRANSACTIONS AND AGREEMENTS CONCERNING THE WARRANTS
There are no agreements, arrangements or understandings between the Company, or any of its directors or executive officers, and any other person with respect to the Eligible Warrants, other than as described in the Offer Materials, including the appointment of Vinyl Equity, Inc. as Exchange Agent and the engagement of legal and other advisors in connection with the Offer. Any material agreements entered into in connection with the Offer will be filed with the SEC as exhibits to the Company’s Tender Offer Statement on Schedule TO, as amended.
8. FINANCIAL INFORMATION REGARDING THE COMPANY
The Company incorporates by reference the Company’s financial statements that were filed in Item 8 of its Annual Report on Form 10-K for the fiscal year ended March 31, 2025, filed with the SEC on June 30, 2025, as well as the Company’s most recently filed unaudited interim financial statements included in its Quarterly Report on Form 10-Q filed with the SEC on November 14, 2025, for the quarter ended September 30, 2025.
The full text of the Quarterly Reports on Form 10-Q and the Annual Report on Form 10-K, as well as the other documents the Company has filed with the SEC prior to, or will file with the SEC subsequent to, the filing of the Company’s Tender Offer Statement on Schedule TO, can be accessed electronically on the SEC’s website at www.sec.gov. Copies of our SEC filings are also available without charge upon written request addressed to Zoomcar Holdings, Inc., at Anjaneya Techno Park, No.147, 1st Floor, Kodihalli, Bangalore, India 560008 or investors@zoomcar.com, attn.: Corporate Secretary. Our telephone number is: +91 8048821871.
Our book value as of September 30, 2025, was approximately $(27.7) million or approximately $(4.02) per share. Book value per share represents our total assets less total liabilities, divided by the number of shares of common stock outstanding as of September 30, 2025.
Our tangible book value as of September 30, 2025, was approximately $(27.7) million or approximately $(4.02) per share. Tangible book value per share represents our total tangible assets (total assets less intangible assets) less total liabilities, divided by the number of shares of common stock outstanding as of September 30, 2025.
9. EXTENSIONS; AMENDMENTS; CONDITIONS; TERMINATION; PLANS
The Company expressly reserves the right, in its reasonable discretion, and at any time or from time to time, to extend the period of time during which the Offer is open. There can be no assurance, however, that the Company will exercise its right to extend the Offer. If the Company extends the Offer, it will give notice of such extension by press release or other public announcement no later than 9:00 a.m., Eastern Time, on the next business day after the previously scheduled Expiration Date of the Offer.
Amendments to the Offer will be made by written notice thereof to the holders of Eligible Warrants. Material changes to information previously provided to holders of Eligible Warrants in this Offer to Exchange or in documents furnished subsequent thereto will be disseminated to holders of Eligible Warrants. Also, should the Company, pursuant to the terms and conditions of the Offer, materially amend the Offer, the Company will ensure that the Offer remains open long enough to comply with U.S. federal securities laws.
21
The minimum period during which an Offer must remain open following any material change in the terms of the Offer or information concerning the Offer (other than a change in price or a change in percentage of securities sought, all of which require up to 10 additional business days) will depend on the facts and circumstances, including the relative materiality of such terms or information.
The Offer is subject to the conditions described in Section 2.E and Section 2.F above, including the Authorized Share Increase condition.
No plans or proposals described in this Offer to Exchange or the related Schedule TO or in any materials sent to the holders of Eligible Warrants in connection with the Offer relate to or would result in the conditions or transactions described in Regulation M-A, Items 1006(c)(1)-(10), except as described under “Background and Purpose of the Offer—Plans or Proposals.”
10. MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES
Certain U.S. Federal Income Tax Consequences to U.S. Holders
The following summary describes certain U.S. federal income tax considerations that may be relevant to U.S. Holders (as defined below) that participate in the Offer to exchange Eligible Warrants for our Common Stock. This summary does not address any other U.S. federal tax, such as estate and gift, alternative minimum, or any state, local, or foreign tax consequences that may be relevant to a holder that participates in the Offer. Moreover, this discussion does not describe U.S. federal income tax considerations that may be relevant to persons that are not United States persons (within the meaning of Section 7701(a)(30) of the Internal Revenue Code of 1986, as amended (the “Code”)) and other Eligible Warrant holders that are not U.S. Holders.
This summary applies only to holders who hold the Eligible Warrants and will hold the Common Stock as a capital asset within the meaning of Section 1221 of the Code. This description does not purport to address all potential tax considerations that may be relevant to a holder based on his, her or its particular situation and does not address the tax considerations applicable to holders that may be subject to special tax rules, such as:
| ● | financial institutions; |
| ● | insurance companies; |
| ● | real estate investment trusts; |
| ● | regulated investment companies; |
| ● | grantor trusts; |
| ● | tax-exempt organizations; |
| ● | dealers or traders in securities or currencies; |
| ● | holders that hold common stock or Eligible Warrants as part of a position in a straddle or as part of a hedging, conversion or integrated transaction for U.S. federal income tax purposes; |
22
| ● | holders that have a functional currency other than the U.S. dollar; |
| ● | holders that received their Eligible Warrants as compensation for the performance of services; |
| ● | holders that actually or constructively own 5% or more of our Shares; or |
| ● | certain U.S. expatriates or long-term U.S. residents. |
If an entity treated as a partnership for U.S. federal income tax purposes holds Eligible Warrants, the tax treatment of a partner in the partnership will generally depend on the status of the partner and the activities of the partnership. Holders owning their Eligible Warrants through a partnership should consult their tax advisors regarding the U.S. federal income tax consequences of exchanging Eligible Warrants for Shares pursuant to the Offer.
This summary is based on the Code, existing and proposed Treasury Regulations, administrative pronouncements and judicial decisions, each as in effect on the date hereof. All of the foregoing are subject to change, possibly with retroactive effect, or to differing interpretations by the Internal Revenue Service or a court, which could alter the tax consequences described herein.
For purposes of this description, a U.S. Holder is a beneficial owner of Eligible Warrants or Common Stock that is for U.S. federal income tax purposes: (i) an individual who is a citizen or resident of the United States; (ii) a corporation (including an entity taxed as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States, any state thereof, or the District of Columbia; (iii) an estate the income of which is subject to U.S. federal income taxation regardless of its source; or (iv) a trust if (x) a court within the United States is able to exercise primary supervision over the administration of such trust and one or more United States persons have the authority to control all substantial decisions of such trust or (y) it has a valid election in effect under applicable U.S. Treasury Regulations to be treated as a United States person.
This summary is included herein as general information only. No statutory or judicial authority directly addresses all aspects of transactions similar to the Offer. We have not sought and do not intend to seek any rulings from the IRS or opinions of counsel regarding the tax consequences described herein, and accordingly, there is no assurance that the IRS will not successfully challenge any of the tax consequences described herein. Accordingly, each Eligible Warrant holder is strongly urged to consult his, her or its own tax advisor with respect to the U.S. federal, state, local and non-U.S. income and other tax consequences of participating in the Offer.
Participation in the Offer
If you participate in the Offer in accordance with the procedures set forth in the Offer, the Company intends to treat your participation for U.S. federal income tax purposes in the applicable manner described below.
23
Though applicable law and regulations are unclear, the Company believes that there is sufficient justification to treat the tender of Eligible Warrants in exchange for Shares as a tax-free exercise or exchange of the rights conferred by the Eligible Warrants. As such, the Company believes that it is more likely than not that if and to the extent you elect to participate in the Offer by tendering Eligible Warrants for Shares of our Common Stock, the Company will treat the transaction as a “recapitalization” or other nonrecognition exchange for U.S. federal income tax purposes. The consequences of such characterization should be that (i) your aggregate tax basis in the new Common Stock received in the exchange should be equal to the aggregate tax basis in your exchanged Eligible Warrants, and (ii) your holding period for the new Common Stock received in the exchange would include your holding period for the exchanged Eligible Warrants. Special tax basis and holding period rules apply to holders who acquired different blocks of Eligible Warrants at different prices or at different times. Holders should consult their tax advisors as to the applicability of these special rules to their particular circumstances.
Although the Company believes the tender pursuant to the Offer is not a taxable exchange, the IRS may take a contrary position and assert that the tender gave rise to taxable income. There is no assurance that a court would agree with the position of the Company or the IRS. Under that approach, the value of the Shares received could serve as the proxy value received, all of which might be subject to income taxation. Alternatively, if the IRS or a court were to view the exchange pursuant to the Offer as the issuance of Shares to an exchanging holder, and the Shares having a value in excess of the Eligible Warrants surrendered by such holder, such excess value could be viewed as a constructive dividend under Section 305 of the Code. Although not free from doubt, we expect that such constructive dividend, if any, should be considered a dividend of common stock on common stock, which generally should be nontaxable for most holders.
HOLDERS ARE ADVISED TO CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF THE EXCHANGE TO THEIR PARTICULAR SITUATION.
11. ADDITIONAL INFORMATION; MISCELLANEOUS
The Company has filed with the SEC a Tender Offer Statement on Schedule TO, of which this Offer to Exchange is a part. This Offer to Exchange does not contain all of the information contained in the Schedule TO and the exhibits to the Schedule TO. The Company recommends that holders review the Schedule TO, including the exhibits, and the Company’s other materials that have been filed with the SEC before deciding on whether to accept the Offer.
The Company is subject to the reporting requirements of the Exchange Act and, in accordance therewith, files and furnishes reports and other information with the SEC. All reports and other documents the Company has filed with or furnished to the SEC, including the Schedule TO relating to the Offer, or will file with or furnish to the SEC in the future, can be accessed electronically on the SEC’s website at www.sec.gov.
24
IF YOU WOULD LIKE COPIES OF ANY OF THE DOCUMENTS TO WHICH WE HAVE REFERRED YOU, OR IF YOU HAVE QUESTIONS ABOUT THE TRANSACTION, YOU MAY CONTACT THE EXCHANGE AGENT OR THE COMPANY BY TELEPHONE OR IN WRITING AT THE FOLLOWING ADDRESS:
Exchange Agent:
Vinyl Equity, Inc.
912 Cherry Street
Winnetka, IL
Email: inquiries@vinylequity.com
Phone: 888-808-4695
Company:
Zoomcar Holdings, Inc.
Anjaneya Techno Park, No.147, 1st Floor, Kodihalli, Bangalore, Karnataka India 560008
Attn: Chief Executive Officer, Chief Legal Officer & General Counsel
Email: investors@zoomcar.com
Phone: +91 80488 21871
ANY QUESTION OR REQUEST FOR ASSISTANCE MAY BE DIRECTED TO THE EXCHANGE AGENT OR THE COMPANY AT THE ADDRESS, PHONE NUMBER AND EMAIL ADDRESS LISTED ABOVE. REQUESTS FOR ADDITIONAL COPIES OF THIS OFFER TO EXCHANGE, THE LETTERS OF TRANSMITTAL AND CONSENT OR OTHER DOCUMENTS RELATED TO THE OFFER MAY ALSO BE DIRECTED TO THE EXCHANGE AGENT OR THE COMPANY.
25
Exhibit 99(a)(1)(B)
LETTER OF TRANSMITTAL
FOR THE COMMON STOCK PURCHASE WARRANTS
ZOOMCAR HOLDINGS, INC.
(Exchange Ratio of Twenty Thousand (20,000) Shares of Common Stock : One (1) Common Warrant)
Representing the privately issued common stock purchase warrants (the “Common Warrants”) of Zoomcar Holdings, Inc. (the “Company”), exercisable for shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”).
The Common Warrants are privately issued and are not publicly traded. There is no market for them. he Common Warrants are held in certificated form and/or in book-entry form, as applicable.
Delivery of Common Warrants. To validly tender Common Warrants, the undersigned must (i) if the Common Warrants are evidenced by certificates, deliver the certificate(s) representing the Common Warrants (or an affidavit of lost certificate and indemnity documentation acceptable to the Company and the Exchange Agent), together with a properly completed and duly executed Letter of Transmittal and any other required documents, or (ii) if the Common Warrants are held in book-entry form, cause such Common Warrants to be delivered through book-entry transfer in accordance with the procedures described in the Offer to Exchange, together with a properly completed and duly executed Letter of Transmittal and any other required documents.
|
A: Name(s) and Address(es) of Registered Owner(s): |
B: Number of Common Warrants Being Exchanged: | C: Shares of Common Stock to be Issued: | D: New Warrants to be Issued: |
| Please fill in exactly as name(s) and address(es) appear on the Common Warrants. | Multiply Column B by 20,000 | N/A | |
No fractional shares will be issued. Common Warrants may only be exchanged for whole shares of Common Stock. Because the Exchange Ratio is expressed as a whole number of shares per Common Warrant, fractional shares are not expected; however, if any fractional shares would otherwise be issuable, the Company will, after aggregating all fractional shares of such holder, round down to the nearest whole share.
SPECIAL ISSUANCE INSTRUCTIONS
To be completed ONLY if the shares of Common Stock for surrendered Common Warrants are to be issued in the name of someone other than the undersigned. Issue the shares to:
Name:_____________________________________________________________________________
Address:___________________________________________________________________________
Tax Identification or Social Security Number:________________________________________________
SPECIAL DELIVERY INSTRUCTIONS
To be completed ONLY if the shares for surrendered Common Warrants are to be delivered to someone other than the undersigned or to the undersigned at an address other than that shown above. Deliver the shares to:
Name:_____________________________________________________________________________
Address:___________________________________________________________________________
The undersigned acknowledges that the undersigned has been advised to consult with its own advisors as to the consequences of participating or not participating in the Offer.
REPRESENTATIONS, WARRANTIES AND AGREEMENTS OF THE WARRANT HOLDER
The undersigned hereby represents, warrants to the Company, and agrees that:
| (a) | the undersigned has full power and authority to tender the Common Warrants and subscribe for all of the shares of the Company which may be received upon exchange of the Common Warrants; |
| (b) | the undersigned has good, marketable and unencumbered title to the Common Warrants, free and clear of all security interests, liens, restrictions, charges, encumbrances, conditional sales agreements or other obligations relating to their exchange, sale or transfer, and not subject to any adverse claim; |
| (c) | on request, the undersigned will execute and deliver any additional documents the Company deems necessary to complete the exchange of the Common Warrants tendered hereby; |
| (d) | the undersigned understands that tenders of Common Warrants pursuant to the Offer and in the instructions hereto will constitute the undersigned’s acceptance of the terms and conditions of the Offer; |
| (e) | the undersigned agrees to all of the terms of the Offer; |
| (f) | the undersigned hereby agrees to permanently waive and renounce any and all “full ratchet” or other price-based anti-dilution rights, if any, that attach to any securities of the Company that it holds that were issued in connection with the Common Warrants that it is tendering for exchange hereby; |
| (g) | the undersigned is an “Accredited Investor” as defined in Rule 501 promulgated under the Securities Act of 1933, as amended. |
All authorities conferred or agreed to be conferred in this Letter of Transmittal shall survive the death or incapacity of the undersigned, and any obligation of the undersigned hereunder shall be binding upon the heirs, personal representatives, executors, administrators, successors, assigns, trustees in bankruptcy, and legal representatives of the undersigned. Except as stated in the Offer, this tender is irrevocable.
Delivery of this Letter of Transmittal and all other documents to an address, or transmission of instructions to an email address, other than as set forth below, does not constitute a valid delivery. Please carefully read this entire Letter of Transmittal, including the accompanying instructions before responding.
2
Exchange Agent:
Vinyl Equity, Inc.
912 Cherry Street
Winnetka, IL
Email: inquiries@vinylequity.com
IMPORTANT—WARRANT HOLDERS SIGN HERE
(Must be signed by registered holder(s) exactly as name(s) appear(s) on the Common Warrants and documents transmitted herewith. U.S. Holders please also obtain and complete IRS Form W-9. Non-U.S. Holders please obtain and complete IRS Form W-8BEN, W-8BEN-E, or other applicable IRS Form W-8.)
Signature:___________________________________________________________________________
Name:____________________________________ Capacity:___________________________________
Phone Number:_________________ Tax Identification or Social Security Number: ____________________
Date:_________________
INSTRUCTIONS FOR LETTER OF TRANSMITTAL
1. Delivery of Letter of Transmittal and Common Warrants. The Letter of Transmittal properly completed and duly executed should be delivered to the Exchange Agent as set forth in the Offer to Exchange. The Exchange Agent will accept email delivery of the Letter of Transmittal at inquiries@vinylequity.com.
THE METHOD OF DELIVERY OF COMMON WARRANT(S) AND ALL OTHER REQUIRED DOCUMENTS IS AT THE ELECTION AND RISK OF THE OWNER. IT IS RECOMMENDED THAT THEY BE SENT BY AN OVERNIGHT OR HAND DELIVERY SERVICE.
2. Inadequate Space. If the space provided on the Letter of Transmittal is inadequate for you to provide the requested information, any information should be listed on a separate schedule to be attached thereto.
3. Signatures of Letter of Transmittal and Endorsements. When the Letter of Transmittal is signed by the registered owner(s) of the Common Warrant(s) listed and surrendered hereby, no endorsements of warrants or separate assignments are required.
If the Common Warrant(s) surrendered is (are) owned of record by two or more joint owners, all such owners must sign the Letter of Transmittal.
If any surrendered Common Warrant(s) are registered in different names, it will be necessary to complete, sign and submit as many separate Letters of Transmittal as there are different registrations.
If the Letter of Transmittal is signed by trustees, executors, administrators, guardians, attorney-in-fact, officers of corporations or others acting in a fiduciary or representative capacity, such persons should so indicate when signing and proper evidence, satisfactory to the Company and/or Exchange Agent, of their authority to do so must be submitted.
4. Special Issuance and Delivery Instructions. Indicate the name and address to which shares are to be issued and/or delivered if different from the name and address of the person(s) signing the Letter of Transmittal.
5. Additional Copies. Additional copies of the Letter of Transmittal may be obtained from the Company or the Exchange Agent at the address listed below.
3
6. Expiration Date. No Letters of Transmittal will be accepted after 5:00 p.m. Eastern Time on March 31, 2026, unless the Offer is extended.
7. Form W-9 and Form W-8. To avoid backup withholding, a tendering warrant holder is required to provide the Exchange Agent with a correct Taxpayer Identification Number (“TIN”) on Form W-9 and to certify, under penalties of perjury, that such number is correct and that such warrant holder is not subject to backup withholding of U.S. federal income tax, and that such warrant holder is a U.S. person (as defined for U.S. federal income tax purposes). If a tendering warrant holder has been notified by the Internal Revenue Service (“IRS”) that such warrant holder is subject to backup withholding, such warrant holder must cross out item (2) of the Certification box of the Form W-9, unless such warrant holder has since been notified by the IRS that such warrant holder is no longer subject to backup withholding.
Failure to provide the information on the Form W-9 may subject the tendering warrant holder to U.S. federal income tax withholding.
Certain warrant holders (including, among others, all corporations and certain foreign individuals and entities) may not be subject to backup withholding. Foreign warrant holders should submit an appropriate and properly completed IRS Form W-8 in order to avoid backup withholding. Such warrant holders should consult a tax advisor to determine which Form W-8 is appropriate.
All questions as to the validity, form and eligibility of any surrender of Common Warrants will be determined by the Company and such determination shall be final and binding. The Company reserves the right to waive any irregularities or defects in the surrender of any Common Warrants. A surrender will not be deemed to have been made until all irregularities have been cured or waived. The Company is under no obligation to waive or to provide any notification of any irregularities or defects in the surrender of any Common Warrants, nor shall the Company be liable for any failure to give such notification.
For Information:
Company
Zoomcar Holdings, Inc.
Anjaneya Techno Park, No.147, 1st Floor
Kodihalli, Bangalore, India 560008
Attn: Chief Legal Officer & General Counsel
Email: investors@zoomcar.com
Phone: +91 8048821871
4
Exhibit 99(a)(1)(C)
LETTER OF TRANSMITTAL AND CONSENT
FOR THE SERIES A COMMON STOCK PURCHASE WARRANTS
ZOOMCAR HOLDINGS, INC.
(Exchange Ratio of ten (10) Shares of Common Stock : One (1) Series A Warrant)
Representing the privately issued Series A common stock purchase warrants (the “Series A Warrants”) of Zoomcar Holdings, Inc. (the “Company”), exercisable for shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”).
The Series A Warrants are privately issued and are not publicly traded. There is no market for them. the Series A Warrants are held in certificated form and/or in book-entry form, as applicable.
Delivery of Series A Warrants. To validly tender Series A Warrants, the undersigned must (i) if the Series A Warrants are evidenced by certificates, deliver the certificate(s) representing the Series A Warrants (or an affidavit of lost certificate and indemnity documentation acceptable to the Company and the Exchange Agent), together with a properly completed and duly executed Letter of Transmittal and any other required documents, or (ii) if the Series A Warrants are held in book-entry form, cause such Series A Warrants to be delivered through book-entry transfer in accordance with the procedures described in the Offer to Exchange, together with a properly completed and duly executed Letter of Transmittal and any other required documents.
| A: Name(s) and Address(es) of Registered Owner(s): | B: Number of Series A Warrants Being Exchanged: | C: Shares of Common Stock to be Issued: | D: New Warrants to be Issued: |
| Please fill in exactly as name(s) and address(es) appear on the Series A Warrants. | Multiply Column B by 10 | N/A | |
No fractional shares will be issued. Series A Warrants may only be exchanged for whole shares of Common Stock. Because the Exchange Ratio is expressed as a whole number of shares per Series A Warrant, fractional shares are not expected; however, if any fractional shares would otherwise be issuable, the Company will, after aggregating all fractional shares of such holder, round down to the nearest whole share.
SPECIAL ISSUANCE INSTRUCTIONS
To be completed ONLY if the shares of Common Stock for surrendered Series A Warrants are to be issued in the name of someone other than the undersigned. Issue the shares to:
Name:_____________________________________________________________________________
Address:___________________________________________________________________________
Tax Identification or Social Security Number:____________________________________________
SPECIAL DELIVERY INSTRUCTIONS
To be completed ONLY if the shares for surrendered Series A Warrants are to be delivered to someone other than the undersigned or to the undersigned at an address other than that shown above. Deliver the shares to:
Name:_____________________________________________________________________________
Address:___________________________________________________________________________
The undersigned acknowledges that the undersigned has been advised to consult with its own advisors as to the consequences of participating or not participating in the Offer.
REPRESENTATIONS, WARRANTIES AND AGREEMENTS OF THE WARRANT HOLDER
The undersigned hereby represents, warrants to the Company, and agrees that:
| (a) | the undersigned has full power and authority to tender the Series A Warrants and subscribe for all of the shares of the Company which may be received upon exchange of the Series A Warrants; |
| (b) | the undersigned has good, marketable and unencumbered title to the Series A Warrants, free and clear of all security interests, liens, restrictions, charges, encumbrances, conditional sales agreements or other obligations relating to their exchange, sale or transfer, and not subject to any adverse claim; |
| (c) | on request, the undersigned will execute and deliver any additional documents the Company deems necessary to complete the exchange of the Series A Warrants tendered hereby; |
| (d) | the undersigned understands that tenders of Series A Warrants pursuant to the Offer and in the instructions hereto will constitute the undersigned’s acceptance of the terms and conditions of the Offer; |
| (e) | the undersigned agrees to all of the terms of the Offer; |
| (f) | the undersigned hereby agrees to permanently waive and renounce any and all “full ratchet” or other price-based anti-dilution rights, if any, that attach to any securities of the Company that it holds that were issued in connection with the Series A Warrants that it is tendering for exchange hereby; |
| (g) | the undersigned is an “Accredited Investor” as defined in Rule 501 promulgated under the Securities Act of 1933, as amended. |
By signing and delivering this Letter of Transmittal and Consent and tendering any Series A Warrants, the undersigned hereby irrevocably consents to and approves (and, if applicable, directs the warrant agent or the Company to effect) any amendment(s) and/or supplement(s) to the governing Series A Warrant instrument as may be necessary or advisable to facilitate the exchange of the Series A Warrants for shares of Common Stock pursuant to the Offer, in each case as described in the Offer Materials (the “Series A Warrant Amendment”).
2
All authorities conferred or agreed to be conferred in this Letter of Transmittal shall survive the death or incapacity of the undersigned, and any obligation of the undersigned hereunder shall be binding upon the heirs, personal representatives, executors, administrators, successors, assigns, trustees in bankruptcy, and legal representatives of the undersigned. Except as stated in the Offer, this tender is irrevocable.
Delivery of this Letter of Transmittal and all other documents to an address, or transmission of instructions to an email address, other than as set forth below, does not constitute a valid delivery. Please carefully read this entire Letter of Transmittal, including the accompanying instructions before responding.
Exchange Agent:
Vinyl Equity, Inc.
912 Cherry Street
Winnetka, IL
Email: inquiries@vinylequity.com
IMPORTANT—WARRANT HOLDERS SIGN HERE
(Must be signed by registered holder(s) exactly as name(s) appear(s) on the Series A Warrants and documents transmitted herewith. U.S. Holders please also obtain and complete IRS Form W-9. Non-U.S. Holders please obtain and complete IRS Form W-8BEN, W-8BEN-E, or other applicable IRS Form W-8.)
Signature:___________________________________________________________________________
Name:____________________________________ Capacity:_________________________________
Phone Number:_________________ Tax Identification or Social Security Number: _____________
Date:_________________
INSTRUCTIONS FOR LETTER OF TRANSMITTAL AND CONSENT
1. Delivery of Letter of Transmittal and Series A Warrants. The Letter of Transmittal properly completed and duly executed should be delivered to the Exchange Agent as set forth in the Offer to Exchange. The Exchange Agent will accept email delivery of the Letter of Transmittal at inquiries@vinylequity.com.
THE METHOD OF DELIVERY OF SERIES A WARRANT(S) AND ALL OTHER REQUIRED DOCUMENTS IS AT THE ELECTION AND RISK OF THE OWNER. IT IS RECOMMENDED THAT THEY BE SENT BY AN OVERNIGHT OR HAND DELIVERY SERVICE.
2. Inadequate Space. If the space provided on the Letter of Transmittal is inadequate for you to provide the requested information, any information should be listed on a separate schedule to be attached thereto.
3. Signatures of Letter of Transmittal and Endorsements. When the Letter of Transmittal is signed by the registered owner(s) of the Series A Warrant(s) listed and surrendered hereby, no endorsements of warrants or separate assignments are required.
3
If the Series A Warrant(s) surrendered is (are) owned of record by two or more joint owners, all such owners must sign the Letter of Transmittal.
If any surrendered Series A Warrant(s) are registered in different names, it will be necessary to complete, sign and submit as many separate Letters of Transmittal as there are different registrations.
If the Letter of Transmittal is signed by trustees, executors, administrators, guardians, attorney-in-fact, officers of corporations or others acting in a fiduciary or representative capacity, such persons should so indicate when signing and proper evidence, satisfactory to the Company and/or Exchange Agent, of their authority to do so must be submitted.
4. Special Issuance and Delivery Instructions. Indicate the name and address to which shares are to be issued and/or delivered if different from the name and address of the person(s) signing the Letter of Transmittal.
5. Additional Copies. Additional copies of the Letter of Transmittal may be obtained from the Company or the Exchange Agent at the address listed below.
6. Expiration Date. No Letters of Transmittal will be accepted after 5:00 p.m. Eastern Time on March 31, 2026, unless the Offer is extended.
7. Form W-9 and Form W-8. To avoid backup withholding, a tendering warrant holder is required to provide the Exchange Agent with a correct Taxpayer Identification Number (“TIN”) on Form W-9 and to certify, under penalties of perjury, that such number is correct and that such warrant holder is not subject to backup withholding of U.S. federal income tax, and that such warrant holder is a U.S. person (as defined for U.S. federal income tax purposes). If a tendering warrant holder has been notified by the Internal Revenue Service (“IRS”) that such warrant holder is subject to backup withholding, such warrant holder must cross out item (2) of the Certification box of the Form W-9, unless such warrant holder has since been notified by the IRS that such warrant holder is no longer subject to backup withholding.
Failure to provide the information on the Form W-9 may subject the tendering warrant holder to U.S. federal income tax withholding.
Certain warrant holders (including, among others, all corporations and certain foreign individuals and entities) may not be subject to backup withholding. Foreign warrant holders should submit an appropriate and properly completed IRS Form W-8 in order to avoid backup withholding. Such warrant holders should consult a tax advisor to determine which Form W-8 is appropriate.
All questions as to the validity, form and eligibility of any surrender of Series A Warrants will be determined by the Company and such determination shall be final and binding. The Company reserves the right to waive any irregularities or defects in the surrender of any Series A Warrants. A surrender will not be deemed to have been made until all irregularities have been cured or waived. The Company is under no obligation to waive or to provide any notification of any irregularities or defects in the surrender of any Series A Warrants, nor shall the Company be liable for any failure to give such notification.
For Information:
Company
Zoomcar Holdings, Inc.
Anjaneya Techno Park, No.147, 1st Floor
Kodihalli, Bangalore, India 560008
Attn: Chief Legal Officer & General Counsel
Email: investors@zoomcar.com
Phone: +91 8048821871
4
Exhibit 99(a)(1)(D)
LETTER OF TRANSMITTAL AND CONSENT
FOR THE SERIES B COMMON STOCK PURCHASE WARRANTS
ZOOMCAR HOLDINGS, INC.
(Exchange Ratio of ten (10) Shares of Common Stock : One (1) Series B Warrant)
Representing the privately issued Series B common stock purchase warrants (the “Series B Warrants”) of Zoomcar Holdings, Inc. (the “Company”), exercisable for shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”).
The Series B Warrants are privately issued and are not publicly traded. There is no market for them. the Series B Warrants are held in certificated form and/or in book-entry form, as applicable.
Delivery of Series B Warrants. To validly tender Series B Warrants, the undersigned must (i) if the Series B Warrants are evidenced by certificates, deliver the certificate(s) representing the Series B Warrants (or an affidavit of lost certificate and indemnity documentation acceptable to the Company and the Exchange Agent), together with a properly completed and duly executed Letter of Transmittal and any other required documents, or (ii) if the Series B Warrants are held in book-entry form, cause such Series B Warrants to be delivered through book-entry transfer in accordance with the procedures described in the Offer to Exchange, together with a properly completed and duly executed Letter of Transmittal and any other required documents.
|
A: Name(s) and Address(es) of Registered Owner(s): |
B: Number of Series B Warrants Being Exchanged: | C: Shares of Common Stock to be Issued: | D: New Warrants to be Issued: |
| Please fill in exactly as name(s) and address(es) appear on the Series B Warrants. | Multiply Column B by 10 | N/A | |
No fractional shares will be issued. Series B Warrants may only be exchanged for whole shares of Common Stock. Because the Exchange Ratio is expressed as a whole number of shares per Series B Warrant, fractional shares are not expected; however, if any fractional shares would otherwise be issuable, the Company will, after aggregating all fractional shares of such holder, round down to the nearest whole share.
SPECIAL ISSUANCE INSTRUCTIONS
To be completed ONLY if the shares of Common Stock for surrendered Series B Warrants are to be issued in the name of someone other than the undersigned. Issue the shares to:
Name:_____________________________________________________________________________
Address:___________________________________________________________________________
Tax Identification or Social Security Number:____________________________________________
SPECIAL DELIVERY INSTRUCTIONS
To be completed ONLY if the shares for surrendered Series B Warrants are to be delivered to someone other than the undersigned or to the undersigned at an address other than that shown above. Deliver the shares to:
Name:_____________________________________________________________________________
Address:___________________________________________________________________________
The undersigned acknowledges that the undersigned has been advised to consult with its own advisors as to the consequences of participating or not participating in the Offer.
REPRESENTATIONS, WARRANTIES AND AGREEMENTS OF THE WARRANT HOLDER
The undersigned hereby represents, warrants to the Company, and agrees that:
| (a) | the undersigned has full power and authority to tender the Series B Warrants and subscribe for all of the shares of the Company which may be received upon exchange of the Warrants; |
| (b) | the undersigned has good, marketable and unencumbered title to the Series B Warrants, free and clear of all security interests, liens, restrictions, charges, encumbrances, conditional sales agreements or other obligations relating to their exchange, sale or transfer, and not subject to any adverse claim; |
| (c) | on request, the undersigned will execute and deliver any additional documents the Company deems necessary to complete the exchange of the Series B Warrants tendered hereby; |
| (d) | the undersigned understands that tenders of Series B Warrants pursuant to the Offer and in the instructions hereto will constitute the undersigned’s acceptance of the terms and conditions of the Offer; |
| (e) | the undersigned agrees to all of the terms of the Offer; |
| (f) | the undersigned hereby agrees to permanently waive and renounce any and all “full ratchet” or other price-based anti-dilution rights, if any, that attach to any securities of the Company that it holds that were issued in connection with the Series B Warrants that it is tendering for exchange hereby; |
| (g) | the undersigned is an “Accredited Investor” as defined in Rule 501 promulgated under the Securities Act of 1933, as amended. |
By signing and delivering this Letter of Transmittal and Consent and tendering any Series B Warrants, the undersigned hereby irrevocably consents to and approves (and, if applicable, directs the warrant agent or the Company to effect) any amendment(s) and/or supplement(s) to the governing Series B Warrant instrument as may be necessary or advisable to facilitate the exchange of the Series B Warrants for shares of Common Stock pursuant to the Offer, in each case as described in the Offer Materials (the “Series B Warrant Amendment”).
All authorities conferred or agreed to be conferred in this Letter of Transmittal shall survive the death or incapacity of the undersigned, and any obligation of the undersigned hereunder shall be binding upon the heirs, personal representatives, executors, administrators, successors, assigns, trustees in bankruptcy, and legal representatives of the undersigned. Except as stated in the Offer, this tender is irrevocable.
Delivery of this Letter of Transmittal and all other documents to an address, or transmission of instructions to an email address, other than as set forth below, does not constitute a valid delivery. Please carefully read this entire Letter of Transmittal, including the accompanying instructions before responding.
2
Exchange Agent:
Vinyl Equity, Inc.
912 Cherry Street
Winnetka, IL
Email: inquiries@vinylequity.com
IMPORTANT—WARRANT HOLDERS SIGN HERE
(Must be signed by registered holder(s) exactly as name(s) appear(s) on the Series B Warrants and documents transmitted herewith. U.S. Holders please also obtain and complete IRS Form W-9. Non-U.S. Holders please obtain and complete IRS Form W-8BEN, W-8BEN-E, or other applicable IRS Form W-8.)
Signature:___________________________________________________________________________
Name:____________________________________ Capacity:_________________________________
Phone Number:_________________ Tax Identification or Social Security Number: _____________
Date:_________________
INSTRUCTIONS FOR LETTER OF TRANSMITTAL AND CONSENT
1. Delivery of Letter of Transmittal and Series B Warrants. The Letter of Transmittal properly completed and duly executed should be delivered to the Exchange Agent as set forth in the Offer to Exchange. The Exchange Agent will accept email delivery of the Letter of Transmittal at inquiries@vinylequity.com.
THE METHOD OF DELIVERY OF SERIES B WARRANT(S) AND ALL OTHER REQUIRED DOCUMENTS IS AT THE ELECTION AND RISK OF THE OWNER. IT IS RECOMMENDED THAT THEY BE SENT BY AN OVERNIGHT OR HAND DELIVERY SERVICE.
2. Inadequate Space. If the space provided on the Letter of Transmittal is inadequate for you to provide the requested information, any information should be listed on a separate schedule to be attached thereto.
3. Signatures of Letter of Transmittal and Endorsements. When the Letter of Transmittal is signed by the registered owner(s) of the Series B Warrant(s) listed and surrendered hereby, no endorsements of warrants or separate assignments are required.
If the Series B Warrant(s) surrendered is (are) owned of record by two or more joint owners, all such owners must sign the Letter of Transmittal.
If any surrendered Series B Warrant(s) are registered in different names, it will be necessary to complete, sign and submit as many separate Letters of Transmittal as there are different registrations.
If the Letter of Transmittal is signed by trustees, executors, administrators, guardians, attorney-in-fact, officers of corporations or others acting in a fiduciary or representative capacity, such persons should so indicate when signing and proper evidence, satisfactory to the Company and/or Exchange Agent, of their authority to do so must be submitted.
4. Special Issuance and Delivery Instructions. Indicate the name and address to which shares are to be issued and/or delivered if different from the name and address of the person(s) signing the Letter of Transmittal.
5. Additional Copies. Additional copies of the Letter of Transmittal may be obtained from the Company or the Exchange Agent at the address listed below.
3
6. Expiration Date. No Letters of Transmittal will be accepted after 5:00 p.m. Eastern Time on March 31, 2026, unless the Offer is extended.
7. Form W-9 and Form W-8. To avoid backup withholding, a tendering warrant holder is required to provide the Exchange Agent with a correct Taxpayer Identification Number (“TIN”) on Form W-9 and to certify, under penalties of perjury, that such number is correct and that such warrant holder is not subject to backup withholding of U.S. federal income tax, and that such warrant holder is a U.S. person (as defined for U.S. federal income tax purposes). If a tendering warrant holder has been notified by the Internal Revenue Service (“IRS”) that such warrant holder is subject to backup withholding, such warrant holder must cross out item (2) of the Certification box of the Form W-9, unless such warrant holder has since been notified by the IRS that such warrant holder is no longer subject to backup withholding.
Failure to provide the information on the Form W-9 may subject the tendering warrant holder to U.S. federal income tax withholding.
Certain warrant holders (including, among others, all corporations and certain foreign individuals and entities) may not be subject to backup withholding. Foreign warrant holders should submit an appropriate and properly completed IRS Form W-8 in order to avoid backup withholding. Such warrant holders should consult a tax advisor to determine which Form W-8 is appropriate.
All questions as to the validity, form and eligibility of any surrender of Series B Warrants will be determined by the Company and such determination shall be final and binding. The Company reserves the right to waive any irregularities or defects in the surrender of any Series B Warrants. A surrender will not be deemed to have been made until all irregularities have been cured or waived. The Company is under no obligation to waive or to provide any notification of any irregularities or defects in the surrender of any Series B Warrants, nor shall the Company be liable for any failure to give such notification.
For Information:
Company
Zoomcar Holdings, Inc.
Anjaneya Techno Park, No.147, 1st Floor
Kodihalli, Bangalore, India 560008
Attn: Chief Legal Officer & General Counsel
Email: investors@zoomcar.com
Phone: +91 8048821871
4
Exhibit 99(a)(1)(E)
LETTER OF TRANSMITTAL AND CONSENT
FOR THE PRE-FUNDED COMMON STOCK PURCHASE WARRANTS
ZOOMCAR HOLDINGS, INC.
(Exchange Ratio of ten (10) Shares of Common Stock : One (1) Pre-Funded Warrant)
Representing the privately issued Pre-Funded common stock purchase warrants (the “Pre-Funded Warrants”) of Zoomcar Holdings, Inc. (the “Company”), exercisable for shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”).
The Pre-Funded Warrants are privately issued and are not publicly traded. There is no market for them. the Pre-Funded Warrants are held in certificated form and/or in book-entry form, as applicable.
Delivery of Pre-Funded Warrants. To validly tender Pre-Funded Warrants, the undersigned must (i) if the Pre-Funded Warrants are evidenced by certificates, deliver the certificate(s) representing the Pre-Funded Warrants (or an affidavit of lost certificate and indemnity documentation acceptable to the Company and the Exchange Agent), together with a properly completed and duly executed Letter of Transmittal and any other required documents, or (ii) if the Pre-Funded Warrants are held in book-entry form, cause such Pre-Funded Warrants to be delivered through book-entry transfer in accordance with the procedures described in the Offer to Exchange, together with a properly completed and duly executed Letter of Transmittal and any other required documents.
| A: Name(s) and Address(es) of Registered Owner(s): | B: Number of Pre-Funded Warrants Being Exchanged: | C: Shares of Common Stock to be Issued: | D: New Warrants to be Issued: |
| Please fill in exactly as name(s) and address(es) appear on the Pre-Funded Warrants. | Multiply Column B by 10 | N/A | |
No fractional shares will be issued. Pre-Funded Warrants may only be exchanged for whole shares of Common Stock. Because the Exchange Ratio is expressed as a whole number of shares per Pre-Funded Warrant, fractional shares are not expected; however, if any fractional shares would otherwise be issuable, the Company will, after aggregating all fractional shares of such holder, round down to the nearest whole share.
SPECIAL ISSUANCE INSTRUCTIONS
To be completed ONLY if the shares of Common Stock for surrendered Pre-Funded Warrants are to be issued in the name of someone other than the undersigned. Issue the shares to:
Name:_____________________________________________________________________________
Address:___________________________________________________________________________
Tax Identification or Social Security Number:________________________________________________
SPECIAL DELIVERY INSTRUCTIONS
To be completed ONLY if the shares for surrendered Pre-Funded Warrants are to be delivered to someone other than the undersigned or to the undersigned at an address other than that shown above. Deliver the shares to:
Name:_____________________________________________________________________________
Address:___________________________________________________________________________
The undersigned acknowledges that the undersigned has been advised to consult with its own advisors as to the consequences of participating or not participating in the Offer.
REPRESENTATIONS, WARRANTIES AND AGREEMENTS OF THE WARRANT HOLDER
The undersigned hereby represents, warrants to the Company, and agrees that:
| (a) | the undersigned has full power and authority to tender the Pre-Funded Warrants and subscribe for all of the shares of the Company which may be received upon exchange of the Warrants; |
| (b) | the undersigned has good, marketable and unencumbered title to the Pre-Funded Warrants, free and clear of all security interests, liens, restrictions, charges, encumbrances, conditional sales agreements or other obligations relating to their exchange, sale or transfer, and not subject to any adverse claim; |
| (c) | on request, the undersigned will execute and deliver any additional documents the Company deems necessary to complete the exchange of the Pre-Funded Warrants tendered hereby; |
| (d) | the undersigned understands that tenders of Pre-Funded Warrants pursuant to the Offer and in the instructions hereto will constitute the undersigned’s acceptance of the terms and conditions of the Offer; |
| (e) | the undersigned agrees to all of the terms of the Offer; |
| (f) | the undersigned hereby agrees to permanently waive and renounce any and all “full ratchet” or other price-based anti-dilution rights, if any, that attach to any securities of the Company that it holds that were issued in connection with the Pre-Funded Warrants that it is tendering for exchange hereby; |
| (g) | the undersigned is an “Accredited Investor” as defined in Rule 501 promulgated under the Securities Act of 1933, as amended. |
By signing and delivering this Letter of Transmittal and Consent and tendering any Pre-Funded Warrants, the undersigned hereby irrevocably consents to and approves (and, if applicable, directs the warrant agent or the Company to effect) any amendment(s) and/or supplement(s) to the governing Pre-Funded Warrant instrument as may be necessary or advisable to facilitate the exchange of the Pre-Funded Warrants for shares of Common Stock pursuant to the Offer, in each case as described in the Offer Materials (the “Pre-Funded Warrant Amendment”).
All authorities conferred or agreed to be conferred in this Letter of Transmittal shall survive the death or incapacity of the undersigned, and any obligation of the undersigned hereunder shall be binding upon the heirs, personal representatives, executors, administrators, successors, assigns, trustees in bankruptcy, and legal representatives of the undersigned. Except as stated in the Offer, this tender is irrevocable.
2
Delivery of this Letter of Transmittal and all other documents to an address, or transmission of instructions to an email address, other than as set forth below, does not constitute a valid delivery. Please carefully read this entire Letter of Transmittal, including the accompanying instructions before responding.
Exchange Agent:
Vinyl Equity, Inc.
912 Cherry Street
Winnetka, IL
Email: inquiries@vinylequity.com
IMPORTANT—WARRANT HOLDERS SIGN HERE
(Must be signed by registered holder(s) exactly as name(s) appear(s) on the Pre-Funded Warrants and documents transmitted herewith. U.S. Holders please also obtain and complete IRS Form W-9. Non-U.S. Holders please obtain and complete IRS Form W-8BEN, W-8BEN-E, or other applicable IRS Form W-8.)
Signature:___________________________________________________________________________
Name:____________________________________ Capacity:_________________________________
Phone Number:_________________ Tax Identification or Social Security Number: _____________
Date:_________________
INSTRUCTIONS FOR LETTER OF TRANSMITTAL AND CONSENT
1. Delivery of Letter of Transmittal and Pre-Funded Warrants. The Letter of Transmittal properly completed and duly executed should be delivered to the Exchange Agent as set forth in the Offer to Exchange. The Exchange Agent will accept email delivery of the Letter of Transmittal at inquiries@vinylequity.com.
THE METHOD OF DELIVERY OF PRE-FUNDED WARRANT(S) AND ALL OTHER REQUIRED DOCUMENTS IS AT THE ELECTION AND RISK OF THE OWNER. IT IS RECOMMENDED THAT THEY BE SENT BY AN OVERNIGHT OR HAND DELIVERY SERVICE.
2. Inadequate Space. If the space provided on the Letter of Transmittal is inadequate for you to provide the requested information, any information should be listed on a separate schedule to be attached thereto.
3. Signatures of Letter of Transmittal and Endorsements. When the Letter of Transmittal is signed by the registered owner(s) of the Pre-Funded Warrant(s) listed and surrendered hereby, no endorsements of warrants or separate assignments are required.
3
If the Pre-Funded Warrant(s) surrendered is (are) owned of record by two or more joint owners, all such owners must sign the Letter of Transmittal.
If any surrendered Pre-Funded Warrant(s) are registered in different names, it will be necessary to complete, sign and submit as many separate Letters of Transmittal as there are different registrations.
If the Letter of Transmittal is signed by trustees, executors, administrators, guardians, attorney-in-fact, officers of corporations or others acting in a fiduciary or representative capacity, such persons should so indicate when signing and proper evidence, satisfactory to the Company and/or Exchange Agent, of their authority to do so must be submitted.
4. Special Issuance and Delivery Instructions. Indicate the name and address to which shares are to be issued and/or delivered if different from the name and address of the person(s) signing the Letter of Transmittal.
5. Additional Copies. Additional copies of the Letter of Transmittal may be obtained from the Company or the Exchange Agent at the address listed below.
6. Expiration Date. No Letters of Transmittal will be accepted after 5:00 p.m. Eastern Time on March 31, 2026, unless the Offer is extended.
7. Form W-9 and Form W-8. To avoid backup withholding, a tendering warrant holder is required to provide the Exchange Agent with a correct Taxpayer Identification Number (“TIN”) on Form W-9 and to certify, under penalties of perjury, that such number is correct and that such warrant holder is not subject to backup withholding of U.S. federal income tax, and that such warrant holder is a U.S. person (as defined for U.S. federal income tax purposes). If a tendering warrant holder has been notified by the Internal Revenue Service (“IRS”) that such warrant holder is subject to backup withholding, such warrant holder must cross out item (2) of the Certification box of the Form W-9, unless such warrant holder has since been notified by the IRS that such warrant holder is no longer subject to backup withholding.
Failure to provide the information on the Form W-9 may subject the tendering warrant holder to U.S. federal income tax withholding.
Certain warrant holders (including, among others, all corporations and certain foreign individuals and entities) may not be subject to backup withholding. Foreign warrant holders should submit an appropriate and properly completed IRS Form W-8 in order to avoid backup withholding. Such warrant holders should consult a tax advisor to determine which Form W-8 is appropriate.
All questions as to the validity, form and eligibility of any surrender of Pre-Funded Warrants will be determined by the Company and such determination shall be final and binding. The Company reserves the right to waive any irregularities or defects in the surrender of any Pre-Funded Warrants. A surrender will not be deemed to have been made until all irregularities have been cured or waived. The Company is under no obligation to waive or to provide any notification of any irregularities or defects in the surrender of any Pre-Funded Warrants, nor shall the Company be liable for any failure to give such notification.
For Information:
Company
Zoomcar Holdings, Inc.
Anjaneya Techno Park, No.147, 1st Floor
Kodihalli, Bangalore, India 560008
Attn: Chief Legal Officer & General Counsel
Email: investors@zoomcar.com
Phone: +91 8048821871
4
Exhibit 99(a)(1)(F)
LETTER OF TRANSMITTAL AND CONSENT
FOR THE BRIDGE PLACEMENT AGENT COMMON STOCK PURCHASE WARRANTS
ZOOMCAR HOLDINGS, INC.
(Exchange Ratio of ten (10) Shares of Common Stock : One (1) Bridge Placement Agent Warrant)
Representing the privately issued Bridge Placement Agent common stock purchase warrants (the “Bridge Placement Agent Warrants”) of Zoomcar Holdings, Inc. (the “Company”), exercisable for shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”).
The Bridge Placement Agent Warrants are privately issued and are not publicly traded. There is no market for them. the Bridge Placement Agent Warrants are held in certificated form and/or in book-entry form, as applicable.
Delivery of Bridge Placement Agent Warrants. To validly tender Bridge Placement Agent Warrants, the undersigned must (i) if the Bridge Placement Agent Warrants are evidenced by certificates, deliver the certificate(s) representing the Bridge Placement Agent Warrants (or an affidavit of lost certificate and indemnity documentation acceptable to the Company and the Exchange Agent), together with a properly completed and duly executed Letter of Transmittal and any other required documents, or (ii) if the Bridge Placement Agent Warrants are held in book-entry form, cause such Bridge Placement Agent Warrants to be delivered through book-entry transfer in accordance with the procedures described in the Offer to Exchange, together with a properly completed and duly executed Letter of Transmittal and any other required documents.
| A: Name(s) and Address(es) of Registered Owner(s): | B: Number of Bridge Placement Agent Warrants Being Exchanged: | C: Shares of Common Stock to be Issued: | D: New Warrants to be Issued: |
| Please fill in exactly as name(s) and address(es) appear on the Bridge Placement Agent Warrants. | Multiply Column B by 10 | N/A | |
No fractional shares will be issued. Bridge Placement Agent Warrants may only be exchanged for whole shares of Common Stock. Because the Exchange Ratio is expressed as a whole number of shares per Bridge Placement Agent Warrant, fractional shares are not expected; however, if any fractional shares would otherwise be issuable, the Company will, after aggregating all fractional shares of such holder, round down to the nearest whole share.
SPECIAL ISSUANCE INSTRUCTIONS
To be completed ONLY if the shares of Common Stock for surrendered Bridge Placement Agent Warrants are to be issued in the name of someone other than the undersigned. Issue the shares to:
Name:_____________________________________________________________________________
Address:___________________________________________________________________________
Tax Identification or Social Security Number:________________________________________________
SPECIAL DELIVERY INSTRUCTIONS
To be completed ONLY if the shares for surrendered Bridge Placement Agent Warrants are to be delivered to someone other than the undersigned or to the undersigned at an address other than that shown above. Deliver the shares to:
Name:_____________________________________________________________________________
Address:___________________________________________________________________________
The undersigned acknowledges that the undersigned has been advised to consult with its own advisors as to the consequences of participating or not participating in the Offer.
REPRESENTATIONS, WARRANTIES AND AGREEMENTS OF THE WARRANT HOLDER
The undersigned hereby represents, warrants to the Company, and agrees that:
| (a) | the undersigned has full power and authority to tender the Bridge Placement Agent Warrants and subscribe for all of the shares of the Company which may be received upon exchange of the Warrants; |
| (b) | the undersigned has good, marketable and unencumbered title to the Bridge Placement Agent Warrants, free and clear of all security interests, liens, restrictions, charges, encumbrances, conditional sales agreements or other obligations relating to their exchange, sale or transfer, and not subject to any adverse claim; |
| (c) | on request, the undersigned will execute and deliver any additional documents the Company deems necessary to complete the exchange of the Bridge Placement Agent Warrants tendered hereby; |
| (d) | the undersigned understands that tenders of Bridge Placement Agent Warrants pursuant to the Offer and in the instructions hereto will constitute the undersigned’s acceptance of the terms and conditions of the Offer; |
| (e) | the undersigned agrees to all of the terms of the Offer; |
| (f) | the undersigned hereby agrees to permanently waive and renounce any and all “full ratchet” or other price-based anti-dilution rights, if any, that attach to any securities of the Company that it holds that were issued in connection with the Bridge Placement Agent Warrants that it is tendering for exchange hereby; |
| (g) | the undersigned is an “Accredited Investor” as defined in Rule 501 promulgated under the Securities Act of 1933, as amended. |
By signing and delivering this Letter of Transmittal and Consent and tendering any Bridge Placement Agent Warrants, the undersigned hereby irrevocably consents to and approves (and, if applicable, directs the warrant agent or the Company to effect) any amendment(s) and/or supplement(s) to the governing Bridge Placement Agent Warrant instrument as may be necessary or advisable to facilitate the exchange of the Bridge Placement Agent Warrants for shares of Common Stock pursuant to the Offer, in each case as described in the Offer Materials (the “Bridge Placement Agent Warrant Amendment”).
All authorities conferred or agreed to be conferred in this Letter of Transmittal shall survive the death or incapacity of the undersigned, and any obligation of the undersigned hereunder shall be binding upon the heirs, personal representatives, executors, administrators, successors, assigns, trustees in bankruptcy, and legal representatives of the undersigned. Except as stated in the Offer, this tender is irrevocable.
2
Delivery of this Letter of Transmittal and all other documents to an address, or transmission of instructions to an email address, other than as set forth below, does not constitute a valid delivery. Please carefully read this entire Letter of Transmittal, including the accompanying instructions before responding.
Exchange Agent:
Vinyl Equity, Inc.
912 Cherry Street
Winnetka, IL
Email: inquiries@vinylequity.com
IMPORTANT—WARRANT HOLDERS SIGN HERE
(Must be signed by registered holder(s) exactly as name(s) appear(s) on the Bridge Placement Agent Warrants and documents transmitted herewith. U.S. Holders please also obtain and complete IRS Form W-9. Non-U.S. Holders please obtain and complete IRS Form W-8BEN, W-8BEN-E, or other applicable IRS Form W-8.)
Signature:___________________________________________________________________________
Name:____________________________________ Capacity:_________________________________
Phone Number:_________________ Tax Identification or Social Security Number: _____________
Date:_________________
INSTRUCTIONS FOR LETTER OF TRANSMITTAL AND CONSENT
1. Delivery of Letter of Transmittal and Bridge Placement Agent Warrants. The Letter of Transmittal properly completed and duly executed should be delivered to the Exchange Agent as set forth in the Offer to Exchange. The Exchange Agent will accept email delivery of the Letter of Transmittal at inquiries@vinylequity.com.
THE METHOD OF DELIVERY OF BRIDGE PLACEMENT AGENT WARRANT(S) AND ALL OTHER REQUIRED DOCUMENTS IS AT THE ELECTION AND RISK OF THE OWNER. IT IS RECOMMENDED THAT THEY BE SENT BY AN OVERNIGHT OR HAND DELIVERY SERVICE.
2. Inadequate Space. If the space provided on the Letter of Transmittal is inadequate for you to provide the requested information, any information should be listed on a separate schedule to be attached thereto.
3. Signatures of Letter of Transmittal and Endorsements. When the Letter of Transmittal is signed by the registered owner(s) of the Bridge Placement Agent Warrant(s) listed and surrendered hereby, no endorsements of warrants or separate assignments are required.
If the Bridge Placement Agent Warrant(s) surrendered is (are) owned of record by two or more joint owners, all such owners must sign the Letter of Transmittal.
If any surrendered Bridge Placement Agent Warrant(s) are registered in different names, it will be necessary to complete, sign and submit as many separate Letters of Transmittal as there are different registrations.
If the Letter of Transmittal is signed by trustees, executors, administrators, guardians, attorney-in-fact, officers of corporations or others acting in a fiduciary or representative capacity, such persons should so indicate when signing and proper evidence, satisfactory to the Company and/or Exchange Agent, of their authority to do so must be submitted.
4. Special Issuance and Delivery Instructions. Indicate the name and address to which shares are to be issued and/or delivered if different from the name and address of the person(s) signing the Letter of Transmittal.
5. Additional Copies. Additional copies of the Letter of Transmittal may be obtained from the Company or the Exchange Agent at the address listed below.
3
6. Expiration Date. No Letters of Transmittal will be accepted after 5:00 p.m. Eastern Time on March 31, 2026, unless the Offer is extended.
7. Form W-9 and Form W-8. To avoid backup withholding, a tendering warrant holder is required to provide the Exchange Agent with a correct Taxpayer Identification Number (“TIN”) on Form W-9 and to certify, under penalties of perjury, that such number is correct and that such warrant holder is not subject to backup withholding of U.S. federal income tax, and that such warrant holder is a U.S. person (as defined for U.S. federal income tax purposes). If a tendering warrant holder has been notified by the Internal Revenue Service (“IRS”) that such warrant holder is subject to backup withholding, such warrant holder must cross out item (2) of the Certification box of the Form W-9, unless such warrant holder has since been notified by the IRS that such warrant holder is no longer subject to backup withholding.
Failure to provide the information on the Form W-9 may subject the tendering warrant holder to U.S. federal income tax withholding.
Certain warrant holders (including, among others, all corporations and certain foreign individuals and entities) may not be subject to backup withholding. Foreign warrant holders should submit an appropriate and properly completed IRS Form W-8 in order to avoid backup withholding. Such warrant holders should consult a tax advisor to determine which Form W-8 is appropriate.
All questions as to the validity, form and eligibility of any surrender of Bridge Placement Agent Warrants will be determined by the Company and such determination shall be final and binding. The Company reserves the right to waive any irregularities or defects in the surrender of any Bridge Placement Agent Warrants. A surrender will not be deemed to have been made until all irregularities have been cured or waived. The Company is under no obligation to waive or to provide any notification of any irregularities or defects in the surrender of any Bridge Placement Agent Warrants, nor shall the Company be liable for any failure to give such notification.
For Information:
Company
Zoomcar Holdings, Inc.
Anjaneya Techno Park, No.147, 1st Floor
Kodihalli, Bangalore, India 560008
Attn: Chief Legal Officer & General Counsel
Email: investors@zoomcar.com
Phone: +91 8048821871
4
Exhibit 99(a)(1)(G)
LETTER OF TRANSMITTAL AND CONSENT
FOR THE SERIES A PLACEMENT AGENT COMMON STOCK PURCHASE WARRANTS
ZOOMCAR HOLDINGS, INC.
(Exchange Ratio of ten (10) Shares of Common Stock : One (1) Series A Placement Agent Warrant)
Representing the privately issued Series A Placement Agent common stock purchase warrants (the “Series A Placement Agent Warrants”) of Zoomcar Holdings, Inc. (the “Company”), exercisable for shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”).
The Series A Placement Agent Warrants are privately issued and are not publicly traded. There is no market for them. the Series A Placement Agent Warrants are held in certificated form and/or in book-entry form, as applicable.
Delivery of Series A Placement Agent Warrants. To validly tender Series A Placement Agent Warrants, the undersigned must (i) if the Series A Placement Agent Warrants are evidenced by certificates, deliver the certificate(s) representing the Series A Placement Agent Warrants (or an affidavit of lost certificate and indemnity documentation acceptable to the Company and the Exchange Agent), together with a properly completed and duly executed Letter of Transmittal and any other required documents, or (ii) if the Series A Placement Agent Warrants are held in book-entry form, cause such Series A Placement Agent Warrants to be delivered through book-entry transfer in accordance with the procedures described in the Offer to Exchange, together with a properly completed and duly executed Letter of Transmittal and any other required documents.
| A: Name(s) and Address(es) of Registered Owner(s): | B: Number of Series A Placement Agent Warrants Being Exchanged: | C: Shares of Common Stock to be Issued: | D: New Warrants to be Issued: |
| Please fill in exactly as name(s) and address(es) appear on the Series A Placement Agent Warrants. | Multiply Column B by 10 | N/A | |
No fractional shares will be issued. Series A Placement Agent Warrants may only be exchanged for whole shares of Common Stock. Because the Exchange Ratio is expressed as a whole number of shares per Series A Placement Agent Warrant, fractional shares are not expected; however, if any fractional shares would otherwise be issuable, the Company will, after aggregating all fractional shares of such holder, round down to the nearest whole share.
SPECIAL ISSUANCE INSTRUCTIONS
To be completed ONLY if the shares of Common Stock for surrendered Series A Placement Agent Warrants are to be issued in the name of someone other than the undersigned. Issue the shares to:
Name:_____________________________________________________________________________
Address:___________________________________________________________________________
Tax Identification or Social Security Number:____________________________________________
SPECIAL DELIVERY INSTRUCTIONS
To be completed ONLY if the shares for surrendered Series A Placement Agent Warrants are to be delivered to someone other than the undersigned or to the undersigned at an address other than that shown above. Deliver the shares to:
Name:_____________________________________________________________________________
Address:___________________________________________________________________________
The undersigned acknowledges that the undersigned has been advised to consult with its own advisors as to the consequences of participating or not participating in the Offer.
REPRESENTATIONS, WARRANTIES AND AGREEMENTS OF THE WARRANT HOLDER
The undersigned hereby represents, warrants to the Company, and agrees that:
| (a) | the undersigned has full power and authority to tender the Series A Placement Agent Warrants and subscribe for all of the shares of the Company which may be received upon exchange of the Warrants; |
| (b) | the undersigned has good, marketable and unencumbered title to the Series A Placement Agent Warrants, free and clear of all security interests, liens, restrictions, charges, encumbrances, conditional sales agreements or other obligations relating to their exchange, sale or transfer, and not subject to any adverse claim; |
| (c) | on request, the undersigned will execute and deliver any additional documents the Company deems necessary to complete the exchange of the Series A Placement Agent Warrants tendered hereby; |
| (d) | the undersigned understands that tenders of Series A Placement Agent Warrants pursuant to the Offer and in the instructions hereto will constitute the undersigned’s acceptance of the terms and conditions of the Offer; |
| (e) | the undersigned agrees to all of the terms of the Offer; |
| (f) | the undersigned hereby agrees to permanently waive and renounce any and all “full ratchet” or other price-based anti-dilution rights, if any, that attach to any securities of the Company that it holds that were issued in connection with the Series A Placement Agent Warrants that it is tendering for exchange hereby; |
| (g) | the undersigned is an “Accredited Investor” as defined in Rule 501 promulgated under the Securities Act of 1933, as amended. |
By signing and delivering this Letter of Transmittal and Consent and tendering any Series A Placement Agent Warrants, the undersigned hereby irrevocably consents to and approves (and, if applicable, directs the warrant agent or the Company to effect) any amendment(s) and/or supplement(s) to the governing Series A Placement Agent Warrant instrument as may be necessary or advisable to facilitate the exchange of the Series A Placement Agent Warrants for shares of Common Stock pursuant to the Offer, in each case as described in the Offer Materials (the “Series A Placement Agent Warrant Amendment”).
2
All authorities conferred or agreed to be conferred in this Letter of Transmittal shall survive the death or incapacity of the undersigned, and any obligation of the undersigned hereunder shall be binding upon the heirs, personal representatives, executors, administrators, successors, assigns, trustees in bankruptcy, and legal representatives of the undersigned. Except as stated in the Offer, this tender is irrevocable.
Delivery of this Letter of Transmittal and all other documents to an address, or transmission of instructions to an email address, other than as set forth below, does not constitute a valid delivery. Please carefully read this entire Letter of Transmittal, including the accompanying instructions before responding.
Exchange Agent:
Vinyl Equity, Inc.
912 Cherry Street
Winnetka, IL
Email: inquiries@vinylequity.com
IMPORTANT—WARRANT HOLDERS SIGN HERE
(Must be signed by registered holder(s) exactly as name(s) appear(s) on the Series A Placement Agent Warrants and documents transmitted herewith. U.S. Holders please also obtain and complete IRS Form W-9. Non-U.S. Holders please obtain and complete IRS Form W-8BEN, W-8BEN-E, or other applicable IRS Form W-8.)
Signature:___________________________________________________________________________
Name:____________________________________ Capacity:_________________________________
Phone Number:_________________ Tax Identification or Social Security Number: _____________
Date:_________________
INSTRUCTIONS FOR LETTER OF TRANSMITTAL AND CONSENT
1. Delivery of Letter of Transmittal and Series A Placement Agent Warrants. The Letter of Transmittal properly completed and duly executed should be delivered to the Exchange Agent as set forth in the Offer to Exchange. The Exchange Agent will accept email delivery of the Letter of Transmittal at inquiries@vinylequity.com.
3
THE METHOD OF DELIVERY OF SERIES A PLACEMENT AGENT WARRANT(S) AND ALL OTHER REQUIRED DOCUMENTS IS AT THE ELECTION AND RISK OF THE OWNER. IT IS RECOMMENDED THAT THEY BE SENT BY AN OVERNIGHT OR HAND DELIVERY SERVICE.
2. Inadequate Space. If the space provided on the Letter of Transmittal is inadequate for you to provide the requested information, any information should be listed on a separate schedule to be attached thereto.
3. Signatures of Letter of Transmittal and Endorsements. When the Letter of Transmittal is signed by the registered owner(s) of the Series A Placement Agent Warrant(s) listed and surrendered hereby, no endorsements of warrants or separate assignments are required.
If the Series A Placement Agent Warrant(s) surrendered is (are) owned of record by two or more joint owners, all such owners must sign the Letter of Transmittal.
If any surrendered Series A Placement Agent Warrant(s) are registered in different names, it will be necessary to complete, sign and submit as many separate Letters of Transmittal as there are different registrations.
If the Letter of Transmittal is signed by trustees, executors, administrators, guardians, attorney-in-fact, officers of corporations or others acting in a fiduciary or representative capacity, such persons should so indicate when signing and proper evidence, satisfactory to the Company and/or Exchange Agent, of their authority to do so must be submitted.
4. Special Issuance and Delivery Instructions. Indicate the name and address to which shares are to be issued and/or delivered if different from the name and address of the person(s) signing the Letter of Transmittal.
5. Additional Copies. Additional copies of the Letter of Transmittal may be obtained from the Company or the Exchange Agent at the address listed below.
6. Expiration Date. No Letters of Transmittal will be accepted after 5:00 p.m. Eastern Time on March 31, 2026, unless the Offer is extended.
7. Form W-9 and Form W-8. To avoid backup withholding, a tendering warrant holder is required to provide the Exchange Agent with a correct Taxpayer Identification Number (“TIN”) on Form W-9 and to certify, under penalties of perjury, that such number is correct and that such warrant holder is not subject to backup withholding of U.S. federal income tax, and that such warrant holder is a U.S. person (as defined for U.S. federal income tax purposes). If a tendering warrant holder has been notified by the Internal Revenue Service (“IRS”) that such warrant holder is subject to backup withholding, such warrant holder must cross out item (2) of the Certification box of the Form W-9, unless such warrant holder has since been notified by the IRS that such warrant holder is no longer subject to backup withholding.
Failure to provide the information on the Form W-9 may subject the tendering warrant holder to U.S. federal income tax withholding.
Certain warrant holders (including, among others, all corporations and certain foreign individuals and entities) may not be subject to backup withholding. Foreign warrant holders should submit an appropriate and properly completed IRS Form W-8 in order to avoid backup withholding. Such warrant holders should consult a tax advisor to determine which Form W-8 is appropriate.
4
All questions as to the validity, form and eligibility of any surrender of Series A Placement Agent Warrants will be determined by the Company and such determination shall be final and binding. The Company reserves the right to waive any irregularities or defects in the surrender of any Series A Placement Agent Warrants. A surrender will not be deemed to have been made until all irregularities have been cured or waived. The Company is under no obligation to waive or to provide any notification of any irregularities or defects in the surrender of any Series A Placement Agent Warrants, nor shall the Company be liable for any failure to give such notification.
For Information:
Company
Zoomcar Holdings, Inc.
Anjaneya Techno Park, No.147, 1st Floor
Kodihalli, Bangalore, India 560008
Attn: Chief Legal Officer & General Counsel
Email: investors@zoomcar.com
Phone: +91 8048821871
5
Exhibit 99(a)(1)(H)
LETTER OF TRANSMITTAL AND CONSENT
FOR THE SERIES A PLACEMENT AGENT COMMON STOCK PURCHASE WARRANTS
ZOOMCAR HOLDINGS, INC.
(Exchange Ratio of ten (10) Shares of Common Stock : One (1) Series A Placement Agent Warrant)
Representing the privately issued Series A Placement Agent common stock purchase warrants (the “Series A Placement Agent Warrants”) of Zoomcar Holdings, Inc. (the “Company”), exercisable for shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”).
The Series A Placement Agent Warrants are privately issued and are not publicly traded. There is no market for them. the Series A Placement Agent Warrants are held in certificated form and/or in book-entry form, as applicable.
Delivery of Series A Placement Agent Warrants. To validly tender Series A Placement Agent Warrants, the undersigned must (i) if the Series A Placement Agent Warrants are evidenced by certificates, deliver the certificate(s) representing the Series A Placement Agent Warrants (or an affidavit of lost certificate and indemnity documentation acceptable to the Company and the Exchange Agent), together with a properly completed and duly executed Letter of Transmittal and any other required documents, or (ii) if the Series A Placement Agent Warrants are held in book-entry form, cause such Series A Placement Agent Warrants to be delivered through book-entry transfer in accordance with the procedures described in the Offer to Exchange, together with a properly completed and duly executed Letter of Transmittal and any other required documents.
|
A: Name(s) and Address(es) of Registered Owner(s): |
B: Number of Series A Placement Agent Warrants Being Exchanged: | C: Shares of Common Stock to be Issued: | D: New Warrants to be Issued: |
| Please fill in exactly as name(s) and address(es) appear on the Series A Placement Agent Warrants. | Multiply Column B by 10 | N/A | |
No fractional shares will be issued. Series A Placement Agent Warrants may only be exchanged for whole shares of Common Stock. Because the Exchange Ratio is expressed as a whole number of shares per Series A Placement Agent Warrant, fractional shares are not expected; however, if any fractional shares would otherwise be issuable, the Company will, after aggregating all fractional shares of such holder, round down to the nearest whole share.
SPECIAL ISSUANCE INSTRUCTIONS
To be completed ONLY if the shares of Common Stock for surrendered Series A Placement Agent Warrants are to be issued in the name of someone other than the undersigned. Issue the shares to:
Name:_____________________________________________________________________________
Address:___________________________________________________________________________
Tax Identification or Social Security Number:____________________________________________
SPECIAL DELIVERY INSTRUCTIONS
To be completed ONLY if the shares for surrendered Series A Placement Agent Warrants are to be delivered to someone other than the undersigned or to the undersigned at an address other than that shown above. Deliver the shares to:
Name:_____________________________________________________________________________
Address:___________________________________________________________________________
The undersigned acknowledges that the undersigned has been advised to consult with its own advisors as to the consequences of participating or not participating in the Offer.
REPRESENTATIONS, WARRANTIES AND AGREEMENTS OF THE WARRANT HOLDER
The undersigned hereby represents, warrants to the Company, and agrees that:
| (a) | the undersigned has full power and authority to tender the Series A Placement Agent Warrants and subscribe for all of the shares of the Company which may be received upon exchange of the Warrants; |
| (b) | the undersigned has good, marketable and unencumbered title to the Series A Placement Agent Warrants, free and clear of all security interests, liens, restrictions, charges, encumbrances, conditional sales agreements or other obligations relating to their exchange, sale or transfer, and not subject to any adverse claim; |
| (c) | on request, the undersigned will execute and deliver any additional documents the Company deems necessary to complete the exchange of the Series A Placement Agent Warrants tendered hereby; |
| (d) | the undersigned understands that tenders of Series A Placement Agent Warrants pursuant to the Offer and in the instructions hereto will constitute the undersigned’s acceptance of the terms and conditions of the Offer; |
| (e) | the undersigned agrees to all of the terms of the Offer; |
| (f) | the undersigned hereby agrees to permanently waive and renounce any and all “full ratchet” or other price-based anti-dilution rights, if any, that attach to any securities of the Company that it holds that were issued in connection with the Series A Placement Agent Warrants that it is tendering for exchange hereby; |
| (g) | the undersigned is an “Accredited Investor” as defined in Rule 501 promulgated under the Securities Act of 1933, as amended. |
By signing and delivering this Letter of Transmittal and Consent and tendering any Series A Placement Agent Warrants, the undersigned hereby irrevocably consents to and approves (and, if applicable, directs the warrant agent or the Company to effect) any amendment(s) and/or supplement(s) to the governing Series A Placement Agent Warrant instrument as may be necessary or advisable to facilitate the exchange of the Series A Placement Agent Warrants for shares of Common Stock pursuant to the Offer, in each case as described in the Offer Materials (the “Series A Placement Agent Warrant Amendment”).
2
All authorities conferred or agreed to be conferred in this Letter of Transmittal shall survive the death or incapacity of the undersigned, and any obligation of the undersigned hereunder shall be binding upon the heirs, personal representatives, executors, administrators, successors, assigns, trustees in bankruptcy, and legal representatives of the undersigned. Except as stated in the Offer, this tender is irrevocable.
Delivery of this Letter of Transmittal and all other documents to an address, or transmission of instructions to an email address, other than as set forth below, does not constitute a valid delivery. Please carefully read this entire Letter of Transmittal, including the accompanying instructions before responding.
Exchange Agent:
Vinyl Equity, Inc.
912 Cherry Street
Winnetka, IL
Email: inquiries@vinylequity.com
IMPORTANT—WARRANT HOLDERS SIGN HERE
(Must be signed by registered holder(s) exactly as name(s) appear(s) on the Series A Placement Agent Warrants and documents transmitted herewith. U.S. Holders please also obtain and complete IRS Form W-9. Non-U.S. Holders please obtain and complete IRS Form W-8BEN, W-8BEN-E, or other applicable IRS Form W-8.)
Signature:___________________________________________________________________________
Name:____________________________________ Capacity:_________________________________
Phone Number:_________________ Tax Identification or Social Security Number: _____________
Date:_________________
INSTRUCTIONS FOR LETTER OF TRANSMITTAL AND CONSENT
1. Delivery of Letter of Transmittal and Series A Placement Agent Warrants. The Letter of Transmittal properly completed and duly executed should be delivered to the Exchange Agent as set forth in the Offer to Exchange. The Exchange Agent will accept email delivery of the Letter of Transmittal at inquiries@vinylequity.com.
THE METHOD OF DELIVERY OF SERIES A PLACEMENT AGENT WARRANT(S) AND ALL OTHER REQUIRED DOCUMENTS IS AT THE ELECTION AND RISK OF THE OWNER. IT IS RECOMMENDED THAT THEY BE SENT BY AN OVERNIGHT OR HAND DELIVERY SERVICE.
2. Inadequate Space. If the space provided on the Letter of Transmittal is inadequate for you to provide the requested information, any information should be listed on a separate schedule to be attached thereto.
3. Signatures of Letter of Transmittal and Endorsements. When the Letter of Transmittal is signed by the registered owner(s) of the Series A Placement Agent Warrant(s) listed and surrendered hereby, no endorsements of warrants or separate assignments are required.
If the Series A Placement Agent Warrant(s) surrendered is (are) owned of record by two or more joint owners, all such owners must sign the Letter of Transmittal.
3
If any surrendered Series A Placement Agent Warrant(s) are registered in different names, it will be necessary to complete, sign and submit as many separate Letters of Transmittal as there are different registrations.
If the Letter of Transmittal is signed by trustees, executors, administrators, guardians, attorney-in-fact, officers of corporations or others acting in a fiduciary or representative capacity, such persons should so indicate when signing and proper evidence, satisfactory to the Company and/or Exchange Agent, of their authority to do so must be submitted.
4. Special Issuance and Delivery Instructions. Indicate the name and address to which shares are to be issued and/or delivered if different from the name and address of the person(s) signing the Letter of Transmittal.
5. Additional Copies. Additional copies of the Letter of Transmittal may be obtained from the Company or the Exchange Agent at the address listed below.
6. Expiration Date. No Letters of Transmittal will be accepted after 5:00 p.m. Eastern Time on March 31, 2026, unless the Offer is extended.
7. Form W-9 and Form W-8. To avoid backup withholding, a tendering warrant holder is required to provide the Exchange Agent with a correct Taxpayer Identification Number (“TIN”) on Form W-9 and to certify, under penalties of perjury, that such number is correct and that such warrant holder is not subject to backup withholding of U.S. federal income tax, and that such warrant holder is a U.S. person (as defined for U.S. federal income tax purposes). If a tendering warrant holder has been notified by the Internal Revenue Service (“IRS”) that such warrant holder is subject to backup withholding, such warrant holder must cross out item (2) of the Certification box of the Form W-9, unless such warrant holder has since been notified by the IRS that such warrant holder is no longer subject to backup withholding.
Failure to provide the information on the Form W-9 may subject the tendering warrant holder to U.S. federal income tax withholding.
Certain warrant holders (including, among others, all corporations and certain foreign individuals and entities) may not be subject to backup withholding. Foreign warrant holders should submit an appropriate and properly completed IRS Form W-8 in order to avoid backup withholding. Such warrant holders should consult a tax advisor to determine which Form W-8 is appropriate.
All questions as to the validity, form and eligibility of any surrender of Series A Placement Agent Warrants will be determined by the Company and such determination shall be final and binding. The Company reserves the right to waive any irregularities or defects in the surrender of any Series A Placement Agent Warrants. A surrender will not be deemed to have been made until all irregularities have been cured or waived. The Company is under no obligation to waive or to provide any notification of any irregularities or defects in the surrender of any Series A Placement Agent Warrants, nor shall the Company be liable for any failure to give such notification.
For Information:
Company
Zoomcar Holdings, Inc.
Anjaneya Techno Park, No.147, 1st Floor
Kodihalli, Bangalore, India 560008
Attn: Chief Legal Officer & General Counsel
Email: investors@zoomcar.com
Phone: +91 8048821871
4
Exhibit 99(a)(1)(K)
Zoomcar Announces Launch of Offer to Exchange Outstanding Warrants for
Common Stock and Commences up to $5.0 Million Rule 506(c) Bridge Financing
Private Placement
Bengaluru, India — (January 23, 2026) Zoomcar Holdings, Inc. (OTCQB:ZCAR), the leading peer-to-peer self-drive car-sharing marketplace in India, today announced the commencement of a voluntary offer to exchange several series of its outstanding warrants (the “Existing Warrants”) for shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”).
Simultaneously, the Company announced the launch of a bridge financing of up to $5,000,000 (the “Bridge Financing”), with a minimum required offering amount of $2,000,000, to be conducted as a private placement pursuant to Rule 506(c) of the Securities Act of 1933.
The Offer to Exchange
The Company is offering to exchange the following classes of Existing Warrants for shares of Common Stock at the ratios set forth below pursuant to the Company’s Tender Offer Statement on Schedule TO filed with the Securities and Exchange Commission (the “SEC”) on January 23, 2026, as may be amended or supplemented from time to time (the “Schedule TO”). The complete terms and conditions of the offer, including instructions for tendering Existing Warrants, are set forth in the Schedule TO and the related offer materials.
The Company is making the Offer to Exchange as part of a broader effort to simplify its capital structure by reducing the number of outstanding warrant instruments and consolidating its equity capitalization. The Company believes this may reduce administrative complexity associated with multiple classes of warrants.
The exchange offer is being made for the following warrants in exchange for the following number of shares of the Company’s Common Stock.
| i. | For each 1 Common Warrant tendered and accepted for exchange, 20,000 shares of Common Stock; |
| ii. | For each 1 Series A Warrant tendered and accepted for exchange, 10 shares of Common Stock; |
| iii. | For each 1 Series B Warrant tendered and accepted for exchange, 10 shares of Common Stock; |
| iv. | for each 1 Pre-Funded Warrant tendered and accepted for exchange, 10 shares of Common Stock; |
| v. | For each 1 Bridge Placement Agent Warrant issued in connection with the Company’s private placement dated June 18, 2024 tendered and accepted for exchange, 10 shares of Common Stock; |
| vi. | For each 1 Placement Agent Warrant issued in connection with issued in connection with the Company’s private placement dated November 5, 2024, tendered and accepted for exchange, 10 shares of Common Stock; and |
| vii. | for each 1 Series A Placement Agent Warrant issued in connection with the Company’s private placement dated November 5, 2024, tendered and accepted for exchange, 10 shares of Common Stock. |
The Company is also soliciting consents from holders of certain classes of warrants to amend governing instruments to facilitate the offer (the “Warrant Amendments”). The exchange is being made in reliance on the exemption provided by Section 3(a)(9) of the Securities Act. No commission or other remuneration will be paid or given, directly or indirectly, to any person for soliciting tenders of the Existing Warrants in connection with the Offer to Exchange.
Holders of Existing Warrants who wish to participate in the Offer to Exchange must validly tender their Existing Warrants in accordance with the procedures and prior to the expiration date set forth in the Schedule TO and related offer materials. Tendered Existing Warrants may be withdrawn at any time prior to the expiration of the offer in accordance with the terms described in the Schedule TO. The Offer to Exchange is subject to the terms and conditions described in the Schedule TO, including, among other things, the Company’s ability to obtain stockholder approval for an amendment to its Certificate of Incorporation to increase the number of authorized shares of Common Stock. The Company expects to seek such stockholder approval at its upcoming annual meeting.
Any shares of Common Stock issued in exchange for Existing Warrants will be subject to contractual lock-up restrictions on transfer, as described in the Schedule TO and the related offer materials. During the applicable lock-up period, holders will be restricted from selling, transferring, or otherwise disposing of such shares, subject to limited customary exceptions. Holders should carefully review the Schedule TO for a description of the lock-up terms and conditions applicable to the exchanged shares.
$5.0 Million Bridge Financing
The Company has commenced a private placement of up to $5.0 million of securities (the “Bridge Financing”), with a minimum required offering amount of $2.0 million. The Bridge Financing is being conducted pursuant to Rule 506(c) of Regulation D under the Securities Act, which permits general solicitation, and participation is limited to verified accredited investors.
The securities offered in the Bridge Financing consist of units priced at $1,000 per unit, with each unit comprising one share of the Company’s Series A Convertible Preferred Stock and one warrant to purchase one share of the Company’s common stock. The Series A Convertible Preferred Stock carries a senior liquidation preference and is initially convertible into shares of common stock at a conversion price of $0.05 per share, and the accompanying warrants are exercisable at an exercise price of $0.0625 per share, in each case subject to adjustment as provided in the definitive transaction documents. Pursuant to the terms of the Bridge Financing, the Company is required to file a registration statement to register the shares of common stock issuable upon conversion of the Series A Convertible Preferred Stock by March 20, 2026, subject to the terms and conditions set forth in the definitive transaction documents.
ThinkEquity LLC is acting as the exclusive placement agent in connection with the Bridge Financing.
The Company intends to use the net proceeds from the Bridge Financing for general corporate purposes, which may include working capital, balance sheet support, and funding the Company’s ongoing operations and strategic initiatives, including costs and expenses that may be incurred in connection with the Company’s previously disclosed efforts to pursue a listing of its common stock on a national securities exchange.
Further Information Regarding the Offer to Exchange
The Offer to Exchange is being made solely pursuant to the Tender Offer Statement on Schedule TO filed by Zoomcar Holdings, Inc. with the Securities and Exchange Commission, as may be amended or supplemented from time to time, and the related offer materials. Holders of Existing Warrants are urged to read the Schedule TO and the related offer materials carefully, as they contain important information regarding the Offer to Exchange.
Questions and requests for assistance regarding the Offer to Exchange, including requests for copies of the Schedule TO and related offer materials, may be directed to the Company at +91 8048821871, investors@zoomcar.com, or Anjaneya Techno Park, No.147, 1st Floor, Kodihalli, Bangalore, India.
2
Further Information Regarding the Bridge Financing
The Bridge Financing is being conducted pursuant to Rule 506(c) of Regulation D under the Securities Act and is available only to verified accredited investors. The securities offered in the Bridge Financing have not been registered under the Securities Act or any state securities laws and may not be offered or sold except pursuant to an applicable exemption from registration.
For additional information regarding the Bridge Financing, verified accredited investors may contact ThinkEquity LLC, the exclusive placement agent for the Bridge Financing, at ThinkEquity, 17 State Street, 41st Floor, New York, New York 10004, or contact the Company at investors@zoomcar.com.
No Offer or Solicitation
THIS PRESS RELEASE IS FOR INFORMATIONAL PURPOSES ONLY AND IS NOT AN OFFER TO PURCHASE OR A SOLICITATION OF AN OFFER TO SELL ANY SECURITIES. THE OFFER TO EXCHANGE IS BEING MADE ONLY PURSUANT TO THE OFFER MATERIALS FILED WITH THE SEC. THE BRIDGE FINANCING IS AVAILABLE ONLY TO VERIFIED ACCREDITED INVESTORS.
Important Information
Holders of Existing Warrants should read the Offer to Exchange and related materials carefully, as they contain important information. These materials have been filed with the SEC as part of a Tender Offer Statement on Schedule TO.
About Zoomcar
Founded in 2013, Zoomcar (OTCQB: ZCAR) is India’s leading peer-to-peer car-sharing marketplace, connecting vehicle owners (“Hosts”) with customers (“Guests”) seeking flexible and affordable mobility solutions. Zoomcar operates an asset-light platform model and serves millions of users across India.
3
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “will,” “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “continue,” “potential,” “aim,” “project,” and similar expressions.
Forward-looking statements in this press release include, without limitation, statements regarding the Offer to Exchange, including the anticipated participation by holders of Existing Warrants, the timing, terms, and completion of the Offer to Exchange, the Company’s ability to satisfy the conditions to the Offer to Exchange (including obtaining stockholder approval for an increase in authorized shares of common stock), the effects of the Offer to Exchange on the Company’s capital structure, and the expected benefits of reducing the number of outstanding warrants. Forward-looking statements also include statements regarding the Bridge Financing, including the anticipated size, timing, and completion of the financing, the use of proceeds therefrom, the Company’s obligation to file a registration statement covering shares issuable upon conversion of the Series A Convertible Preferred Stock, and the Company’s ability to comply with the terms of the Bridge Financing. In addition, forward-looking statements include statements regarding the Company’s previously disclosed efforts to pursue a listing of its common stock on a national securities exchange.
These forward-looking statements are based on management’s current expectations and assumptions and are subject to significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others: the level of participation in the Offer to Exchange; the Company’s ability to meet the conditions to the Offer to Exchange; delays in or failure to obtain required stockholder approvals; the Company’s ability to complete the Bridge Financing on acceptable terms or at all; market, economic, and capital markets conditions; regulatory developments; the Company’s operating performance and liquidity; the timing and outcome of any registration statement filing or review process; and the possibility that the Company may delay, modify, suspend, or abandon the Offer to Exchange, the Bridge Financing, or its listing efforts.
Actual results may differ materially from those expressed or implied by these forward-looking statements. Additional risks and uncertainties are described under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended March 31, 2025, its subsequent Quarterly Reports on Form 10-Q, and other filings with the U.S. Securities and Exchange Commission.
Except as required by law, the Company undertakes no obligation to publicly update or revise any forward-looking statements to reflect events or circumstances after the date of this press release, whether as a result of new information, future events, or otherwise.
4